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ABSTRACT

Neurodegeneration, a progressive loss of nerve cells (neurons), occurs in many
neurological disorders, including Alzheimer’s and Parkinson’s diseases, as well as in
the aging brain. Disruption of microtubules in neurons and the aggregation of proteins
associated with them is the hallmark of neurodegeneration. Nevertheless, the cause of
this disorder is largely unknown, and no effective drugs are available to treat the
disease processes. Therefore, there is a need to understand the molecular mechanisms
that drive the assembly and disassembly of microtubules during neurite outgrowth and
differentiation. Evidence suggests that nerve growth factor (NGF) induces neurite
outgrowth from PC12 cells by activating the receptor tyrosine kinase (TrkA) and the
phosphoinositide-3-kinase (PI3K) pathway. G-protein-coupled receptors (GPCRs), as
well as heterotrimeric G proteins, are also involved in regulating neurite outgrowth.
However, the possible connection between these pathways and how they might
ultimately converge to regulate the assembly and organization of MTs during neurite
outgrowth is not well understood. In my dissertation, I tested the hypothesis that G, an
important component of the GPCR pathway, is involved in neuronal differentiation by
modulating MT assembly, and that the disruption of the interaction between G and
tubulin/MT in neurons will inhibit neurite outgrowth. To test this hypothesis, PC12 cells
were used because they respond to NGF with growth arrest and exhibit a typical
phenotype of neuronal cells sending out neurites. In addition, primary hippocampal and
cerebellar neurons in culture were used for the study. It was found that NGF promoted
the interaction of G with MTs and stimulated MT assembly. In further support for a
vi

role of G-MT interaction in neuronal differentiation, it was observed that
overexpression of G in PC12 cells induced neurite outgrowth in the absence of added
NGF. In addition, by using inhibitors of PI3K, I provide evidence that G may
coordinate with PI3K signaling to regulate MT assembly and neurite outgrowth. I found
that G-sequestering peptide GRK2i inhibited neurite formation, disrupted MTs, and
induced axonal damage, indicating the involvement of G in this process. Because it
was shown in earlier studies that prenylation and subsequent methylation/demethylation
of  subunits are required for the G-MTs interaction in vitro, in the current study, smallmolecule

inhibitors

targeting

prenylated

methylated

protein

methyl

esterase

(PMPMEase) were tested, and I found that these inhibitors disrupted G and MT
organization, affected cellular morphology, and inhibited neurite outgrowth. Altogether,
this study demonstrates that the interaction of G with MTs could be a determining
factor for MT rearrangement and the induction of neurite outgrowth, and that interfering
with this process may trigger an early stage of neurodegeneration. This knowledge will
be helpful for designing and developing novel therapies targeting G-MT mediated
pathway that is altered during neurodegeneration.
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CHAPTER 1: INTRODUCTION

1.1. Microtubule assembly and dynamics

Microtubules (MTs) are intracellular polymeric structures found in all eukaryotic
cells. Along with the intermediate filaments and the actin-based microfilaments, MTs
constitute the structural framework of the cell, the cytoskeleton. One of the features that
make MTs fascinating objects of study is their remarkable diversity in function. These
functions include chromosome movement during cell division, neuronal differentiation,
organelle transport within the cell, and the maintenance of cell morphology. These
functions of MTs are critically dependent upon their ability to polymerize and
depolymerize (Desai and Mitchinson, 1997). MTs in cells exist as dynamic and stable
populations, each one called upon to carry out distinct cellular functions (Gelfand and
Berchadsky, 1991). For instance, during mitosis, the interphase network of MTs
radiating throughout the cell changes into a bipolar spindle that mediates the accurate
segregation of chromosomes. The half-life of MTs changes from 5–10 min. to 30 sec.–1
min. during this transition (McNally, 1996). On the other hand, the stability of the MTs
increases significantly during neuronal differentiation (Bulinski and Gundersen, 1991).

The major component of MTs is the heterodimeric protein tubulin, consisting of 
and  subunits, which are assembled into linear protofilaments. The protofilaments
associate laterally to form the microtubule, a 25 nm-wide hollow cylindrical polymeric
structure (Desai and Mitchinson, 1997). Due to the asymmetry of the  tubulin
1

heterodimer, MTs are polar structures with two distinct ends. These ends possess
different polymerization rates: a slow growing minus end with an exposed -tubulin
subunit, and a fast growing plus end, at which the -tubulin subunit is exposed (Jiang
and Akhmanova, 2011; Sakakibara et al., 2013). MT assembly occurs in two phases:
nucleation, which is facilitated by a third tubulin isoform, -tubulin; and elongation,
during which -tubulin heterodimers are added to the plus end (Desai and Mitchinson,
1997; Conde and Cáceres, 2009). Tubulin is a unique guanine nucleotide-binding
protein containing one exchangeable binding site and one non-exchangeable binding
site. GTP at both sites is needed for optimal assembly, and GTP at the exchangeable
site is hydrolyzed after assembly (David-Pfeuty et al., 1977; Nogales et al., 1998; Singh
et al., 2008). This hydrolysis creates an MT consisting largely of GDP tubulin, but a
small region of GTP-bound tubulin, called a “GTP cap,” remains at the end. This cap
allows MTs to polymerize. The loss of the cap results in a transition from growth to
shortening (called a catastrophe), whereas the reacquisition of the GTP cap results in a
transition from shortening to growing (called a rescue). This behavior, known as
dynamic instability, allows MTs to be remodeled rapidly in order to reach specific targets
more effectively (Mitchison and Kirschner, 1984; Carlier et al., 1989; Desai and
Mitchinson, 1997; Gundersen et al., 2004). The MT assembly process is depicted in
Figure 1 (adopted with permission from Conde and Cáceres, 2009).

MT assembly and stability can be affected by a wide variety of proteins. In this
regard, microtubule-associated proteins (MAPs) play a very important role. Members of
this group of proteins, such as MAP2 and tau, are known to promote MT assembly and
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stabilize MTs in vivo and in vitro (Murphy and Borisy, 1975; Margolis et al., 1986;
Kowalski and Williams, 1993; Gamblin et al., 1996). The phosphorylation of MAPs is
critical for their function, since phosphorylated MAPs separate from MTs, causing MTs
to become more susceptible to disassembly and destabilization (Ebneth et al., 1999;
van der Vaart et al., 2009). Destabilization of MTs can be promoted by a large number
of proteins collectively termed catastrophe promoters, as they favor the transition of
MTs from elongation to shortening. Examples of these proteins include stathmin/Op18
(a small heat-stable protein that is abundant in many types of cancer cells), katanin, and
some kinesin-related motor proteins (Belmont and Mitchison, 1996; Kline-Smith and
Walczak, 2002). Also, many drugs are known to alter tubulin polymerization, and they
are considered valuable tools in studying the mechanisms of MT assembly. Some of
these drugs, such as nocodazole, depolymerize MTs, whereas others, such as taxol,
promote MT assembly (McGuire et al., 1988; Vasquez et al., 1997). Even though MTs
are composed of / tubulin heterodimers in all eukaryotic cells, MTs exhibit great
functional diversity. One possible explanation is that both  and  tubulin undergo a
series of post-translational modifications that allow MTs to engage in a variety of cellular
activities

(Hammond

et

al.,

2008).

These

modifications

include

tyrosination/detyrosination, acetylation, glutamylation, and phosphorylation (Wloga and
Gaertig, 2010). Although much effort has been made in identifying and characterizing
the cellular factors that regulate MT assembly and dynamics, the precise spatial and
temporal control of the process is not clearly understood.

3

Figure 1. Assembly/disassembly of MTs. MTs are polymerized from heterodimers consisting
of  and  tubulin. A third tubulin isoform, -tubulin, serves as a template for nucleation. GTP
binding to tubulin is necessary for MT assembly to occur. GTP is hydrolyzed to GDP when
tubulin is incorporated within MT. In MTs, GDP is bound to tubulin except at the plus (+) end,
where tubulin is still in GTP-bound form, establishing a GTP cap. This cap allows MTs to
polymerize (assembly). When the cap is lost, tubulin is depolymerized and MTs begin to shrink.
Reprinted by permission from Macmillan Publishers Ltd: Nature Reviews Neuroscience, (Conde
and Cáceres (2009).
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1.2. G protein-mediated signaling

Traditionally, G proteins function as signal transducers in transmembrane
signaling pathways that consist of three elements: G protein-coupled receptors
(GPCRs), G proteins, and effectors. The GPCR family of proteins is highly diverse.
More than 1,000 genes encoding GPCRs are found in the human genome (Fredriksson
et al., 2003; Wang et al., 2012). GPCRs participate in the regulation of a wide variety of
physiological functions, including neurotransmission, immune system function, cell
growth and differentiation, and hormonal signaling. Participation in such a multitude of
processes makes GPCRs a very attractive drug target, and approximately 30% of
commercially available drugs are designed to target GPCRs (Salon et al., 2011).
GPCRs consist of seven transmembrane domains, connected by three extracellular and
three intracellular loops. The extracellular region is responsible for agonist binding
(neurotransmitters, hormones, and odorants, among others), and the intracellular region
is responsible for interacting with heterotrimeric G proteins (Latek et al., 2012).

The G protein heterotrimer is composed of guanine nucleotide-binding  plus
subunits, which forms a tight association under non-denaturing conditions. In
humans, there are 21 isoforms of G subunits, 6 G isoforms, and 12 isoforms of G
(Downes and Gautam, 1999). G protein heterotrimers are typically classified into four
classes, depending on the G subunit: Gs (for stimulation of adenylyl cyclase), Gi
(for inhibition of adenylyl cyclase), Gq (which regulates phospholipase), and G12-13,
which is involved in the regulation of monomeric G proteins and other molecules, such
5

as PKC (Simon et al., 1991; Neves et al., 2002). The traditional pathway for GPCR
signaling is shown in Figure 2.

The G protein-signaling cascade begins with the agonist-induced activation of a
GPCR, which allows GTP to bind to the  subunit of the heterotrimer, and subsequently,
the GTP-bound activated G changes its association with G in a manner that permits
both subunits to participate in the regulation of intracellular effector molecules. Typical
effectors of G signaling include adenylyl cyclase, phospholipase C, phospholipase A2,
ion channels, and several kinases and transcription factors. Termination of the signal
occurs when GTP bound to the subunit is hydrolyzed by its intrinsic GTPase activity,
which causes its functional dissociation from the effector and reassociation with 
(Gilman, 1987; Dohlman et al., 1991; Neves et al., 2002; McCudden et al., 2005). While
the signal-transducing ability of heterotrimeric G proteins was once believed to depend
fully on the  subunit, it has now become clear that the  subunit is capable of
interacting with numerous effector molecules to influence a variety of signaling
pathways (Sternweis, 1994; Smrcka, 2008). Among the effector molecules interacting
with G are phospholipases, K+ and Ca2+ channels, GPCR kinases, members of the
MAPK signaling pathway, monomeric G proteins, regulators of G protein signaling (RGS
proteins), and phosphoinositide-3 kinase (PI3K) (Ueda et al., 1994; Wickman et al.,
1994; Faure et al., 1994; Ford et al., 1998; Shi et al., 2001; Smrcka, 2008).

6
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Figure 2. GPCR signaling through heterotrimeric G proteins. Upon agonist activation of the
GPCR, the G subunit exchanges GDP for GTP, causing the heterotrimer to dissociate and
both  and  subunits activate a variety of effector molecules. Signal termination occurs when
the GTP-bound G hydrolyzes the nucleotide, causing the  heterotrimer to reform.
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1.3. The interaction of G proteins with microtubules

In addition to their function in the downstream signaling of GPCRs, recent
evidences indicate that G proteins associate with several subcellular compartments,
including MTs, and participate in both cell division and differentiation (Cote et al., 1997;
Willard and Crouch, 2000; Wu et al., 2001; Sarma et al., 2003). For example, G protein
 subunit antisense oligonucleotides have been shown to inhibit cell proliferation and to
disorganize the mitotic spindle in mammalian cells (Wu et al., 2001). A non-traditional G
protein signaling pathway has been shown to be involved in regulating the mitotic
spindle for centrosome/chromosome movements in cell division in C. elegans,
Drosophila, and mammals. Components of this pathway include several proteins, such
as the Gi class of G proteins, GoLoco domain-containing proteins (such as the
mammalian LGN, which contains N-terminal Leu-Gly-Asn repeats), AGS3 (Activator of
G protein Signaling 3), and RGS (regulators of G protein signaling) (Gotta and Ahringer,
2001; Schaefer et al., 2001; Kimple et.al., 2002; Fuse et al., 2003; Du and Macara,
2004; Sanada and Tsai, 2005; Siegrist and Doe, 2005). While Gi was shown to
regulate MT pulling forces for chromosome movements, G was found to be involved
in spindle positioning and orientation. Several GPCRs capable of triggering neurite
outgrowth have been identified. These receptors are coupled to Gi/o, G12/13 or Gs
families of G proteins (Reinoso et al., 1996; Lotto et al., 1999; He et al., 2006). Thus, G
proteins appear to provide a link between hormones or neurotransmitters and cell
division, differentiation, and MTs.

8

1.4. Regulation of MT assembly by  and  subunits of heterotrimeric G proteins
in vitro

Direct interactions between tubulin and G protein subunits ( and ) have been
demonstrated earlier and these interactions modulate MT assembly in vitro (Figure 3)
(Wang et al., 1990; Roychowdhury and Rasenick, 1997; Roychowdhury et al., 1999;
Roychowdhury et al., 2006). It was found that G inhibits MT assembly and promotes
tubulin depolymerization by activating the intrinsic GTPase activity of tubulin
(Roychowdhury et al., 1999). Thus, G may act as a GAP (GTPase-activating protein)
for tubulin and may increase the dynamic behavior of MTs by removing the GTP cap.
The G subunit has the opposite effect on tubulin polymerization, as it was found that
G promotes MT assembly in vitro. While 12 stimulated MT assembly, 11 had no
effect, suggesting that specificity exists among G isoforms. Furthermore, a mutant
12, 12(C68S), which does not undergo prenylation and subsequent carboxyterminal processing on the  subunit, does not stimulate the formation of MTs
(Roychowdhury and Rasenick, 1997). This result suggests that prenylation of the 
subunit is a major determinant for the observed difference. Reconstituted heterotrimers
were shown to be inactive in the modulation of MT assembly (Roychowdhury et al.,
2006), suggesting that G protein activation is required for functional coupling between
G/G and tubulin/MTs. The result also suggests that G protein coupled receptors
(GPCRs) may be involved in the regulation of MT assembly and dynamics in vivo by
mobilizing G protein subunits to bind to MTs. By doing so, GPCRs may control a variety
of cellular activities.
9

Figure 3. Regulation of MT assembly by G protein-mediated signaling. Based on the in
vitro results using purified tubulin and G protein subunits (Roychowdhury and Rasenick, 1997;
Roychowdhury et al., 1999; Roychowdhury et al., 2006), it is suggested that the G inhibits MT
assembly and promotes MT disassembly by interacting with tubulin-GTP or the GTP cap of
growing MTs and initiating GTP hydrolysis of tubulin. G, on the other hand, promotes MT
assembly. The G heterotrimer is functionally inactive, but it can be activated either by
agonist-mediated or agonist-independent pathways. Upon activation, G dissociates from G
subunits, and both subunits then interact with tubulin/MTs and modulate assembly/dynamics.
(Adapted from Roychowdhury and Rasenick, 2008).
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1.5. Regulation of MT assembly by G in cultured cell lines

In recent years, our laboratory has been focusing on understanding the functional
consequences of G-dependent regulation of MT assembly in vivo. By using the antimitotic agent nocodazole, it has been demonstrated that the assembly/disassembly of
MTs alters the tubulin-G interaction in cultured PC12 and NIH3T3 cells (Montoya et
al., 2007). While MT depolymerization by nocodazole inhibited the interactions between
tubulin and G, this inhibition was reversed when MT assembly was restored by the
removal of nocodazole. The result suggests that G might be involved in promoting MT
assembly and/or stabilization of MTs in vivo as demonstrated in vitro. More recently, we
found that the activation of GPCRs - and 2-adrenergic receptors) stimulated MT
assembly in NIH3T3 cells. The stimulation of MT assembly in response to GPCR
activation correlated with increased association of Gwith polymerized tubulin,
suggesting that GPCRs may utilize G to regulate MT assembly in vivo (Gutierrez et
al., manuscript under preparation).

1.6. The carboxy-terminal of the G protein-coupled receptor kinase 2 (GRK2) as
an inhibitor of G-mediated signaling

The G protein-coupled receptor kinase 2 (GRK2), also known as -adrenergic
receptor kinase 1 (ARK1), is a member of the GRK family of kinases, a group of
proteins involved in the regulation of GPCR desensitization (Kamal et al., 2012). GRK2
11

is ubiquitously expressed and is found in the cytosol. Upon agonist activation of
GPCRs, G binds to GRK2 and recruits it to the membrane, where it phosphorylates
the GPCR, inducing its clathrin-mediated internalization and allowing desensitization
(Claing et al., 2002).

GRK2 binds to G by means of a domain that is located in the carboxy-terminal
region of the kinase (Fushman et al., 1996; Kamal et al., 2011). Since the GRK2-G
interaction is highly specific, the carboxy terminus of GRK2 (GRK2ct) has been widely
used as a peptide inhibitor of G-signaling, including -adrenergic receptor
desensitization, adenylate cyclase activity, activation of the mitogen-activated protein
kinase pathway, and regulation of PI3K signaling (Koch et al., 1994a; Crespo et al.,
1994; Perrino et al., 2005; Smrcka et al., 2008; Kamal et al., 2011). A very important
feature of GRK2ct is its ability to inhibit signaling through a variety of G effector
molecules without disrupting normal G protein activation and signaling. This derives
from the fact that the presence of GRK2ct inhibits pathways that Gis known to
regulate, but has no effect on pathways controlled by G subunits (Koch et al., 1994a;
Koch et al., 1994b; Inglese et al., 1994; Smrcka, 2008). Although the precise
mechanism for the selectivity of GRK2ct remains unclear, the use of the peptide
provides a very helpful tool in attempting to understand G-mediated cellular functions.
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1.7. Prenylation of  subunit of G is required for its binding to MTs and
stimulation of MT assembly

A number of proteins undergo a process of post-translational modification known
as prenylation. This consists of the attachment of 15-carbon farnesyl or 20-carbon
geranylgeranyl groups to a carboxy-terminal motif termed CAAX, where “C” is a
cysteine, “A” is an aliphatic amino acid, and “X” is any amino acid (Gelb et al., 2006).
Approximately 2% of eukaryotic proteins are known to undergo prenylation, denoting
the importance of this modification (Nalivaeva and Turner, 2001). Prenylation can affect
the subcellular localization of proteins, as well as their biological function, and can play
a part in mediating protein-protein interactions (Novelli and D’Apice, 2012).

The prenylation pathway (Figure 4) consists of three enzymatic steps, the first of
which is the addition of a prenyl group to the cysteine residue of the carboxy-terminal
CAAX motif, followed by the cleavage of the tripeptide (AAX). The terminal carboxylic
acid group then undergoes methylation, which is then catalyzed by the prenylated
protein methyl transferase (PPMTase, also known as isoprenylcysteine carboxyl
methyltransferase, or ICMT). PMPMEase readily hydrolyzes ester bonds of the
methylated prenylated proteins, thus making the methylation step reversible (WinterVann and Casey, 2005; Lamango, 2005; Gelb et al., 2006). For this reason, the last
enzymatic step in this series of reactions has become an attractive target for drug
development, since defects in protein prenylation have been documented in human

13

cancers and neurodegenerative diseases (Seabra et al., 1995; Pereira-Leal et al., 2001;
Ghobrial and Adjei, 2002).

The  subunit of G is known to undergo prenylation and subsequent
methylation of the carboxy-terminal cysteine, and this modification is believed to
influence protein activity and subcellular localization (Fung et al., 1990; Takida and
Wedegaertner, 2003; Marrari et al., 2007). In this regard, prenylation has been found to
play an important role in the G-mediated regulation of MT assembly, since a
prenylation-deficient mutant G(C68S), which does not undergo prenylation and
subsequent carboxy-terminal processing on the  subunit, fails to bind to MTs and does
not

stimulate

tubulin

polymerization

(Roychowdhury

and

Rasenick,

1997;

Roychowdhury et al., 2006). Therefore, inhibitors of the prenylation pathway could be a
valuable tool to study the functional regulation of MTs through G
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Figure 4. The protein prenylation pathway. Protein prenylation is catalyzed by a series of
three enzymatic reactions that culminate with the methylation of the C-terminal prenylated
cysteine, which is the only reversible step in the enzymatic pathway. Figure adapted with
permission (Amissah et al., 2011).
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1.8. Actin filaments or microfilaments

Actin filaments (AFs) are another important component of the cytoskeleton. AFs
participate in a variety of cellular processes, such as cell division, differentiation,
morphogenesis, intracellular trafficking, and the generation of the motile force of the
cells. AFs are capable of generating specialized structures within the cell, such as
stress fibers, filopodia, and lamellipodia (Bailly and Condeelis, 2002; Sekino et al.,
2007; Cingolani and Goda, 2008). The biochemical basis for actin’s versatility to
participate in these cellular processes is its ability to transition from globular G-actin
(monomeric) to filamentous F-actin (polymerized). Actin polymerization is essentially a
condensation reaction, with the initial association of an unstable dimer, followed by the
formation of a stable trimer that represents the nucleus of polymerization, and finally,
the elongation phase, during which the actin monomers are rapidly assembled (Grazi
and Trombetta, 1985; Wang et al., 1989; Dos Remedios et al., 2003). Actin possesses
intrinsic ATPase activity, given that ATP hydrolysis plays a critical role in the
polymerization process. AFs are polar structures, with polymerization occurring on the
barbed end (ATP-bound), and depolymerization occurring preferentially on the pointed
end, which consists of ADP-bound actin (Lee and Dominguez, 2010). Actin
polymerization is tightly regulated by a number of actin-binding proteins (ABPs). Small
GTPases—such as Rho, Cdc42, and Rac—are involved in the regulation of actin
dynamics during the formation of filopodia and lamellipodia (Ettienne-Manneville and
Hall, 2002). Another well-characterized example of ABPs is the WASP complex, which
plays a role in promoting actin polymerization (Takenawa and Tsuetsugu, 2007). On the
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other hand, the ABP known as actin-depolymerizing factor, or ADF/cofilin, is involved in
the regulation of actin filament severing and depolymerization (Pak et al., 2008).

1.9. Neuronal cytoskeleton

The cytoskeleton plays a key role in inducing neurite outgrowth and maintaining
the highly asymmetrical shape and structural polarity of neurons that are essential for
neuronal function. Neuronal outgrowth is a complex process in which two distinct
domains emerge from the cell body: a long, thin axon that transmits signals, and
multiple shorter dendrites, which are specialized primarily for receiving signals. When
fully differentiated through axon and dendrite elongation, this unique morphology allows
neurons to achieve precise connectivity between appropriate sets of neurons, which is
crucial for the proper functioning of the nervous system (Figure 5). While many signals
are known to drive neuronal outgrowth, it is the assembly and disassembly of
cytoskeletal structures embodied within neurite extension and growth cone formation
that are essential for establishing appropriate synaptic connections and signal
transmission.

MTs form dense parallel arrays in axons and dendrites that are required for the
growth and maintenance of these neurites. Unlike MTs, actin filaments in neurons are
enriched in growth cones and organized into long bundles forming filamentous
protrusions, or filopodia, or veil-like sheets of branched actin forming lamellipodia. The
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interactions between these two cytoskeletal filaments are important for advancement of
growth cones and axon guidance (Witte and Bradke, 2008; Geraldo and GordonWeeks, 2009). In the axon, MTs are bundled by MAPs, with the plus end oriented
toward the nerve terminal. They are also found in the cell body and dendritic processes,
where they provide structural support and help to stabilize dendrite branches (Goldstein
and Yang, 2000).

During neuronal differentiation, the organization of MTs needs to be remodeled
rapidly, and MT stability changes depending on their cellular localization. The stability of
neuronal MTs is predominantly regulated by the reversible tyrosination/detyrosination of
 tubulin. This process involves the removal of C-terminal tyrosine (Tyr-tubulin) by an
enzyme called tubulin carboxypeptidase, thus generating detyrosinated tubulin
(glutaminated-tubulin or Glu-tubulin). This modification is reversible, as the enzyme
tubulin tyrosine ligase is able to catalyze the addition of tyrosine back onto the Cterminus of Glu-tubulin, thus forming Tyr-tubulin again (Barra et al., 1973; Raybin and
Flavin, 1977; Argarana et al., 1978; Schröder et al., 1985; Paturle et al., 1989; Ersfeld et
al., 1993; Janke and Kneussel, 2010). The detyrosinated form of tubulin (Glu-tubulin) is
generally linked to stable MTs, as long-lived MTs are detyrosinated in different cell
types (Schulze et al., 1987; Janke and Kneussel, 2010). Thus, in neurons, the MTs
containing detyrosinated tubulin are predominantly found in axons, where highly stable
MTs are required (Paturle-Lafanechere et al., 1994). In the growth cones, where highly
dynamic MTs are needed to facilitate advancement, MTs are enriched in Tyr-tubulin
(Janke and Kneussel, 2010).
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Figure 5. Neuronal cytoskeleton. MTs (red) are shown in the axon, dendrites, and the central
domain of the growth cone. Tau (blue), a microtubule-associated protein (MAP), is found in the
axon, where it participates in MT bundling. Actin filaments (green) are present in the growth
cone and dendrites, where they form specialized structures such as lamellipodia and filopodia.
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1.10. Key regulators of MTs/actin cytoskeleton during neurite outgrowth

It is clear that cytoskeletal components are able to detect biochemical signals
and respond to them in order to change neuronal cell morphology. However, the precise
signaling pathways that lead to this unique organization of the cytoskeleton are not
clearly understood (Li and Gundersen, 2008). PC12 cells have been used extensively
for these studies, since they respond to nerve growth factor (NGF) with growth arrest
and exhibit a typical phenotype of neuronal cells sending out neurites (Greene and
Tischler, 1976). The receptor commonly associated with this process is receptor
tyrosine kinase (TrkA) by which NGF exerts its effect (Patapoutian and Reichardt,
2001). PI3K appears to be the key molecule in this pathway, and regulates localized
assembly of MTs/actin filaments by downstream Akt/GSK3 pathways (Cantley, 2002;
Zhou et al., 2004). The Rho and Ras families of small GTPases also emerged as critical
players in regulating the actin-MT cytoskeleton by modulating downstream effectors,
including serine threonine kinase, p21-activated kinase, ROCK, and mDia (Govek et al.,
2005; Hall and Lalli, 2010). GPCRs, as well as and  subunits of heterotrimeric G
proteins, have also been shown to regulate neurite outgrowth (Reinoso et al., 1996;
Kwon et al., 1998; Lotto et al., 1999; He et al., 2005; Igarashi et al., 1993; Sarma et al.,
2003; Wolfgang et al., 2004; Sachdev et al., 2007; Yu et al., 2009). Earlier studies to
understand the role of G proteins in neurite outgrowth were mainly focused on 
subunits of G proteins because  subunits were thought to be the physiological
mediator of GPCR signaling. More recently, G has also been shown to regulate
neurite outgrowth in primary hippocampal neurons by interacting with Tctex-1, a light20

chain component of the cytoplasmic dynein motor complex. It has been proposed that
G might accomplish this function by linking extracellular signals to localized regulation
of MTs and actin filaments through Rho GTPase and downstream MT modulators
(Sachdev et al., 2007; Wang and Wong, 2009). PI3K is also a downstream effector of
G in GPCR signaling (Stoyanov et al., 1995; Stephens et al., 1997), and recent
results suggest that the activation of PI3K/Akt pathway by NGF is, in part, mediated
through the subunit (Wu and Wong, 2005a and 2005b; Wang and Wong, 2009).
These studies collectively suggest a role of G in neuronal differentiation. However, the
mechanisms by which G acts to regulate neurite outgrowth are still poorly understood.
The prevailing view is that G would activate downstream signals and involve MAPs
and other MT modulators to regulate MT assembly and neurite outgrowth (Sachdev et
al., 2007; Wang and Wong, 2009).

1.11. Aberrant organization of the cytoskeleton in neurodegeneration

Neurodegeneration is a pathological condition in which a loss of neuronal
structure and function occurs progressively, ultimately leading to neuronal cell death
(Jellinger, 2009). Many alterations in normal cellular processes take place during
neurodegeneration, including defects in protein folding, mitochondrial dysfunction,
impaired intracellular transport, and increased oxidative stress (Jellinger, 2010). In
addition, one of the hallmarks of neurodegeneration is the presence of abnormal protein
aggregates in neuronal cells (Cairns et al., 2004). These pathological protein inclusions
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are present in many neurodegenerative diseases, such as Alzheimer’s and Parkinson’s
diseases. Importantly, further characterization of these abnormal protein deposits has
revealed the presence of cytoskeletal proteins, such as tubulin and MAPs (Goedert et
al., 2001; Al-Chalabi and Miller, 2003; Skovronsky et al., 2006; Jellinger, 2010).

Alzheimer’s disease (AD) is the most common neurodegenerative disorder,
affecting ~10% of people over 70 (Plassman et al., 2007). Amyloid plaques (consisting
of extracellular deposits of A peptides) and neurofibrillary tangles (NFT) constitute the
two major neuropathological alterations in the brains of AD patients. NFTs are formed of
abnormally aggregated, paired helical filaments consisting of the MAP, tau. Under
normal conditions, tau binds to MTs, stabilizing neuronal structure and integrity. In AD
brain, the MT structure is disrupted, and tau is hyperphosphorylated and does not bind
to MTs (Drechsel et al., 1992; Ittner and Gotz, 2010). Figure 6 shows NFT formation
and MT disruption in neuronal cells.

Cytoskeletal alterations are also present in Parkinson’s disease (PD). synuclein is a major component of the cytopathological markers of PD, the Lewy bodies,
but cytoskeletal proteins—such as tubulin, MAP1, MAP2, and neurofilaments—are also
present (Alonso et al., 2008; Amniai et al., 2008; Gustav et al., 2010). Although synuclein-induced neurotoxicity is believed to play a major role in the pathogenesis of
PD, recent evidence suggests that disruptions in the microtubule cytoskeleton may also
play an important role (Cardoso et al., 2012).
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Other neurodegenerative diseases, such as Pick’s disease, frontotemporal lobar
degeneration, progressive supranuclear palsy, and amyotrophic lateral sclerosis, are
also known to include cytoskeletal alterations as part of the underlying disruptions in
cellular machinery (Cairns et al., 2004; Brunden et al., 2009). Additionally, aberrant
cytoskeletal structure and function is now believed to play a critical role in the
development of other neurological disorders, such as schizophrenia and depression,
with alterations in the microtubule network as a key feature (Arnold et al., 1991; Gozes,
2011; Wong et al., 2013).

The majority of the research and drug discovery effort in the area of
neurodegenerative diseases in the past focused on these pathological markers.
However, the cause of these disorders remains largely unknown. Most importantly, no
effective drugs are currently available to treat neurodegenerative disorders, suggesting
that there is a critical knowledge gap in our understanding of how the disease is
triggered and how it progresses. Recent results suggest that MT assembly is severely
compromised in AD and PD brains (Cash et al., 2003; Buxton et al., 2010; Cartelli et al.,
2010, 2013). This could play a significant role in triggering early phases of the disease,
which could be followed by the demise of neurons and neuronal death.
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Figure 6. Tau in healthy neuronal cells and formation of NFTs in diseased cells. In normal
neurons, tau participates in MT stabilization, helping to preserve neuronal integrity and
facilitating neuronal function. During neurodegeneration, tau becomes hyperphosphorylated and
does not bind to MTs, forming abnormal aggregates that are deposited in the cells. This leads to
impaired MT stability, axonal damage, and overall loss of neuronal integrity. Reprinted by
permission from Macmillan Publishers Ltd: Nature Reviews Drug Discovery (Brunden et al.,
2009).
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1.12. Hypothesis and specific aims

Neuronal differentiation and neurite formation are dependent on a highly
specialized organization of the MT/actin cytoskeleton. However, the precise molecular
mechanism and the specific cellular signals that drive these cytoskeletal changes are
poorly understood. This knowledge is critically important because severe cytoskeletal
alterations occur during neurodegeneration. Previous results from our laboratory
indicated that the  subunit of heterotrimeric G proteins binds to tubulin and stimulates
MT assembly in vitro. We have also demonstrated that the tubulin-G interaction is
critical for MT assembly/stability in cultured PC12 cells. I hypothesize that G is
involved in neuronal differentiation by modulating MT assembly, and that the disruption
of the interaction between G and tubulin/MT in neurons will disrupt the MT/actin
cytoskeleton and inhibit neuritogenesis. This hypothesis was tested by addressing the
following specific aims:

Specific Aim 1: Determine if G and its interaction with MTs is important for neurite
outgrowth.

Specific Aim 2: Determine if blocking the interactions between G and MTs alters MT
organization and inhibits neurite outgrowth.

Specific Aim 3: Determine the signaling pathways involved in G-dependent
regulation of MT assembly and neurite outgrowth.
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CHAPTER 2: MATERIALS AND METHODS

2.1. Cell culture and NGF treatment
PC12 cells (pheochromocytoma cells derived from the adrenal gland of Rattus
norvegicus) (ATCC, Manassas, VA), were grown in 75-cm2 culture flasks at 37 °C in
Dulbecco’s Modified Eagle’s Medium (DMEM, CellGro, Manassas, VA) (4.5 g/L glucose,
L-glutamine, without pyruvate), supplemented with 10% bovine calf serum and
antibiotics (100 U/mL penicillin and 100 g/mL streptomycin) in 10% CO2. For NGF
treatment, PC12 cells were treated with 100 ng/mL of NGF (Sigma-Aldrich, St. Louis,
MO) dissolved in complete media for three consecutive days. Control cells without NGF
were also grown under the same conditions. For quantitative assessment of neurite
outgrowth, PC12 cells were only treated with NGF for 2 days instead of 3, given that the
density of neurite outgrowth does not allow for proper tracing of neurites belonging to a
specific cell body. SH-SY5Y neuroblastoma cells (a kind gift from Dr. M. Narayan’s lab,
UTEP) were grown in 75-cm2 flasks in a 1:1 mixture of DMEM and F-12 media
(Invitrogen), supplemented with 10% fetal bovine serum and antibiotics (100 U/mL
penicillin and 100 µg/mL streptomycin) in 10% CO2.

2.2. PMPMEase inhibitors and G-blocking peptide (GRK2i)
Using phenylmethylsulfonyl fluoride (PMSF) as a prototypical molecule, the laboratory
of Dr. N. Lamango (Florida A&M University) recently synthesized high-affinity specific
inhibitors of PMPMEase (Aguilar et al., 2011). Two such inhibitors, 2-transgeranylthioethanesulfonyl fluoride (L-23) and 2-trans, trans-farnesylthioethanesulfonyl
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fluoride (L-28) were used in our study. Stock solutions of 20 mM L-23, L-28, or PMSF
were prepared in dimethyl sulfoxide (DMSO) and diluted in tissue culture media to final
concentrations of 1, 5, or 10 M, and added to the cells as indicated in the figures. The
DMSO concentration in the culture media never exceeded 0.05%. In addition, a control
experiment was performed in the presence of a similar concentration of DMSO. The
G-blocking

peptide,

GRK2i

(WKKELRDAYREAQQLVQRVPKMKNKPRS),

was

obtained from Tocris Bioscience (Bristol, UK), and it consists of the G-binding domain
of the G protein-coupled receptor kinase 2 (GRK2) and acts as a cellular G
antagonist. A stock solution of the peptide (1 mM) was prepared in 10% DMSO, and
was added to the cells at final concentrations of 1, 5, or 10 M as indicated in the figure.
The DMSO concentration in the culture media never exceeded 0.1% as indicated
above, and the control experiment was also performed in the presence of 0.1% DMSO
in the culture media.

2.3. Gallein and PI3K inhibitors
The small molecule inhibitor gallein, which has been shown to bind to G and inhibit
downstream activation of PI3-K(Lehman et al., 2008) was obtained from Tocris
Bioscience. In addition, two highly specific and widely validated PI3K inhibitors,
wortmannin and LY294002 (Sigma-Aldrich), were employed. Stock solutions of all three
inhibitors were prepared in DMSO (20 mM gallein, 10 mM Wortmannin, and 14.5 mM
LY294002) and further diluted in culture media right before being added to the cells.
Control experiments in the presence of similar concentrations of DMSO were conducted
for each inhibitor.
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2.4. Extraction of cytoskeletal (CSK) and soluble protein (SOL) fractions
Cells were grown on 100- or 150-mm plates to 70% confluence over 1–2 days as
described in section 2.1. The plates were used in duplicates for each condition.
Cytoskeletal (CSK; enriched in MTs) and soluble (SOL; enriched in tubulin dimers)
fractions were prepared by extracting soluble proteins in a MT stabilizing (MS) buffer as
described previously (Montoya et al., 2007) with a minor modification adopted from
Marklund et al. (1996). Briefly, cells were rinsed and incubated with 0.5–1 mL of MS
buffer (0.1 M PIPES, pH 6.9, 2 M glycerol, 5 mM MgCl2, 2 mM EGTA, 0.5% Triton X100, 1 mM DTT, and 10 M GTP) supplemented with protease inhibitor cocktail (Roche
Applied Science, Indianapolis, IN) for ~10 min at room temperature. Subsequently, the
cells were removed mechanically (using a cell scraper) and centrifuged at 10,000 × g for
10 min. The supernatant constitutes the SOL fraction and the cell pellets represent the
CSK fraction that includes the tubulin and actin polymers. Pellets were then washed in
PEM buffer (100 mm PIPES, pH 6.9, 2 mM EGTA, 1 mM MgCl2) and resuspended in
PEM buffer containing 1 mM DTT, 10 M GTP, and protease inhibitor cocktail, followed
by incubation on ice for 30 min. Protein extraction from the pellets was performed by
sonicating the samples on ice for 1 min and clarifying by centrifugation at 10,000 × g for
10 min. The resulting supernatant was saved as CSK fraction. The protein
concentration of the samples was determined by a previously described method
(Bradford, 1976), using bovine serum albumin (BSA) as standard. The subcellular
fractionation procedure yielded highly reproducible results in technically replicated
samples used for each condition in a given experiment.
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2.5. Preparation of whole cell lysates
PC12 cells were grown under the conditions described in section 2.1. For nocodazole
treatment, cells were grown on 150 mm culture dishes until they reached ~80%
confluence. Cells were treated with the drug (10 μM) for 4 hours. Whole cell lysates
were also prepared. After treatment or transfection, culture media was removed, cells
were washed with PBS, and then lysed by incubation in 1 ml lysis buffer (10 mM TrisHCl, pH 7.9, 1.5 mM MgCl2, 0.3 M sucrose, 0.1% Triton X-100, 1 mM DTT, and 10 M
GTP) supplemented with protease inhibitor cocktail, for 10 min at room temperature.
Cells were then scraped and sonicated for 1 min, followed by centrifugation at 10,000 ×
g for 10 min. The supernatants constituted whole cell lysates, and the protein
concentration was determined by the Bradford (1976) assay.

2.6. Electrophoresis and immunoblotting
Samples for immunoblotting were subjected to SDS-polyacrylamide gel (10%)
electrophoresis, followed by electrotransfer onto nitrocellulose membranes (Laemmli,
1970; Towbin et al., 1970). The membranes were blocked in 5% nonfat dry milk in TBS
(10 mM Tris-HCl and 150 mM NaCl, pH 7.4) for 2 h at room temperature, followed by
overnight incubation at 4 °C with mouse monoclonal anti--tubulin (DMIA, SigmaAldrich, 1:200), rabbit polyclonal anti-GSanta Cruz Biotechnology, 1:250), goat
polyclonal anti-actin (Santa Cruz Biotechnology, 1:250), or rabbit monoclonal anti-Akt
and anti-pAkt (Cell Signaling Technology, 1:500) antibodies in TBS containing 0.01%
BSA as previously described (Montoya et al., 2007). The membranes were washed
three times with 0.05% Tween-20 in TBS (TBST) and incubated with the appropriate

29

HRP-conjugated secondary antibodies (goat anti-mouse or goat anti-rabbit from
Promega, Madison, WI; 1:1000, or donkey anti-goat from Santa Cruz Biotechnology;
1:1000) in TBST containing 0.01% BSA for 1 h. For sensitive detection, the
chemiluminescence (ECL) technique (SuperSignal West Pico Chemiluminescent
Substrate)

was

used

according

to

the

manufacturer’s

instructions

(Pierce

Biotechnology, Rockford, IL). Quantitative analysis of the protein bands was performed
with the LabWorks image acquisition and analysis software (UVP Laboratory Products,
Upland, CA).

2.7. Immunoprecipitation
For immunoprecipitation experiments, 100 L aliquots of cellular fractions (~0.25–1
mg/mL of protein) were incubated with or without anti-G antibody (5-10 l), or nonspecific rabbit IgG for 1 h at 4 °C, followed by an overnight incubation (4 °C) with 100 L
of 50% protein A-sepharose (Amersham Biochemical, Piscataway, NJ), as previously
described (Montoya et al., 2007). Samples were then centrifuged at 10,000 × g for 10
min, and the supernatants (SUP) were saved. The pellets (immunocomplex) were
washed with PBS and eluted with 3% SDS Laemmli sample buffer containing 0.15 M
dithiothreitol (DTT) and boiled in a water bath for 5 min. Samples were then clarified by
centrifugation. Both IP and SUP fractions were then subjected to immunoblotting using
anti-tubulin or anti-actin antibodies as described in section 2.6.
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2.8. Overexpression of G
PC12 cells were transiently co-transfected with yellow fluorescent protein (YFP)-tagged
pcDNA3.1 plasmids encoding for G1 and G2 subunits. The expression plasmids were
generously provided by Dr. N. Gautam (Washington University, St. Louis, MO). A
plasmid encoding only YFP (pcDNA3-YFP, Addgene, Cambridge, MA) was used as a
control, and the plasmids were transfected separately (G1 and G2) or co-transfected
to generate the G12 combination. Cells were transfected with the plasmids using the
Lipofectamine LTX PLUS reagent (Invitrogen, Carlsbad, CA) according to the
manufacturer’s instructions. Briefly, PC12 cells were seeded on glass coverslips using
12-well plates at a density of 50,000 cells /well, and incubated overnight under normal
growth conditions. The following day, the cells were transfected with a mixture of
Lipofectamine LTX PLUS containing 2 µg of each plasmid (dissolved in antibiotic-free
media) and incubated overnight in normal growth media. Cells were monitored for
protein expression (YFP fluorescence) and morphological changes using differential
interference contrast (DIC) images at different time points (24, 48, and 72 h), with a
Zeiss Axiovert 200 fluorescence microscope equipped with a GFP filter. For confocal
microscopic analysis, the cells were fixed and processed as described in section 2.8.

2.9. Immunofluorescence and confocal microscopy
For confocal microscopic analysis, cells were allowed to attach to immunocytochemistry
slides (Lab-TEK II mounted on glass slides, Thermo Fisher Scientific, Rochester, NY) or
seeded on glass coverslips using 12-well plates, and were grown overnight as
described in section 2.1. Cells were then treated with or without NGF and/or inhibitors
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as indicated and subsequently fixed by the addition of ice-cold 100% methanol
(previously cooled to -20 °C) and incubated at -20 °C for 6 min as described (Montoya
et al., 2007). The cells were then rinsed three times in PBS, blocked for 1 h at room
temperature in 5% normal goat serum (NGS) (Sigma-Aldrich) in PBS, followed by
overnight incubation at 4 °C with primary antibodies (anti--tubulin, anti-G, and antiactin1:100 dilution) in 1% NGS in PBS. Detailed description of these antibodies is
provided in section 2.6. The slides were rinsed as before and incubated with the
appropriate secondary antibodies (tetramethyl rhodamine (TMR)-conjugated goat antimouse IgG, fluorescein isothiocyanate (FITC)-conjugated goat anti-rabbit IgG, Alexa
Fluor 350-conjugated donkey anti-goat IgG; Molecular Probes-Invitrogen, Carlsbad, CA,
or TMR congujated bovine anti-goat, Santa Cruz Biotechnology) for 2 h at room
temperature and in the dark to diminish photo-bleaching effects. The slides were then
mounted with DAKO mounting media (DAKO Corporation, Carpenteria, CA), or with
ProLong Gold anti-fade reagent with DAPI (Invitrogen, for nuclear staining), and
covered with coverslip. High-resolution, digital, fluorescent images were captured by
employing inverted, confocal laser-scanning microscopy (model LSM 700; Zeiss,
Thornwood, NY), utilizing a Plan-Apochromat 63x/1.40 immersion-oil DIC objective and
assisted with 2009 ZEN software (Zeiss, Thornwood, NY). DAPI and Alexa Fluor 350
(blue), FITC (green), and TMR (red) were excited with laser emissions of 405-, 488-,
and 555-nm wavelengths, respectively. G-transfected cells were only labeled with
anti--tubulin and TMR antibodies.
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2.10. Co-localization analysis
To quantitatively assess the degree of co-localization between G and MTs, regions of
interest (ROIs) were delimited within cells to decrease the background fluorescence
contribution. Co-localization was calculated using a squared Manders’ overlap
coefficient of the defined signals, performed on a pixel-by-pixel basis, which represents
an accurate degree of co-localization. The Manders’ overlap coefficient provides values
within the range from 0 to 1; a value of 0 means that there are no pixels within the
selected ROI with overlapped signals, whereas a value of 1 represents perfectly colocalized pixels (Manders et al., 1993). The values for selected ROIs were acquired
from images taken from 10–12 cells from different microscope fields, using the ZEN
2009 software. In order to rule out bleed-through of the fluorescent labels, control
coverslips were prepared with a single fluorophore and were further imaged under the
same microscope settings used with the double-labeled coverslips. In addition, the
same microscope settings were applied when imaging the cells for co-localization
analysis.

2.11. 3-D image analysis
Image stacks were imported into Volocity 3-D Image Analysis Software (Version 6.0;
Perkin Elmer Corporation, Waltham, MA) operating on a Macintosh Pro computer. In
Volocity’s Restoration module, a point-spread function was calculated to deconvolve the
native image stack using iterative restoration (80%, 20 iterations max). In Volocity’s
Visualization module, a joystick control aided in free flight through the newly rendered 3D image for selection of proper viewing approaches alongside labeled neuronal
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processes of the cell. These instances within the moving sequence were bookmarked,
and the bookmarks were dropped into the software’s movie-making interface. The final
sequence was exported as a QuickTime movie (see Supplementary Movie 1), and still
frames from this movie sequence were selected to generate Figure 12.

2.12. Neurite outgrowth assessment
For neurite outgrowth measurement, cells were fixed and processed for confocal
microscopy using a mouse monoclonal anti-tubulin antibody and a rabbit polyclonal G
antibody, followed by labeling with rhodamine- and FITC-conjugated secondary
antibodies. Due to the fast photo-bleaching of the FITC fluorophore, the cells were only
imaged using rhodamine staining for the purpose of neurite outgrowth assessment.
Cells were viewed using the 40x objective with a Zeiss LSM 700 confocal microscope.
The coverslips were scanned from left to right, and 8–10 microscope fields were
randomly selected. For each field, neurites were traced and measured using the 2009
ZEN software (Zeiss), and at least 100 cells from three independent experiments were
scored for each condition. A cell was considered as neurite-bearing if it contained at
least one neuronal process that was longer than the cell body.

2.13. Neuronal primary cultures from rat-brain cerebellum and hippocampus
Primary cultures of cerebellum and hippocampus neurons were prepared from brains of
postnatal day (1–2) Sprague Dawley rats as previously described (Goslin et al., 1998;
Gomez et al., 2002). The cerebellum and hippocampus were dissected from the brain
and dissociated by papain digestion for 1 h at room temperature, followed by
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mechanical disaggregation with a Pasteur pipette. Cells were then counted using a
hemocytometer and subsequently seeded on glass coverslips using 12-well plates at a
density of 250,000 cells/well (for confocal microscopy), or on 100-mm culture dishes at
a density of 1x107 cells/plate (for subcellular fractionation experiments). Both glass
coverslips and culture dishes were pre-coated with 0.01% poly-D-lysine and 10 µg/mL
laminin dissolved in PBS. Neuronal cultures were maintained in Neurobasal A media
containing B27 supplement (Invitrogen), Glutamax, antibiotics (100 U/mL penicillin, and
100 µg/mL streptomycin), and mitotic inhibitors (10 µM uridine and 10 µM fluorodeoxyuridine). Cultures were fed every other day by replacing half of the media with
fresh, complete media (including mitotic inhibitors). Neuronal primary cultures were
used for confocal microscopy and subcellular fractionation experiments after they
became fully differentiated (at least seven days in culture).

2.14. Differential nuclear staining (DNS) assay for cytotoxicity
To determine the levels of cytotoxicity caused by the experimental compounds (L-28, L23, PMSF, GRK2i) a previously described DNS assay adapted for high-throughput
screening was used (Lema et al., 2011). This assay uses two fluorescent nucleic acid
intercalators, Hoechst 33342 (Hoechst) and propidium iodide (PI). Briefly, PC12 cells
were seeded in a 96-well plate format and incubated with NGF and inhibitors. One hour
before image capturing, a staining mixture of Hoechst and PI at a final concentration of
1 µg/mL for each dye was added to the cells. Subsequently, cells were imaged in livecell mode using a BD Pathway 855 Bioimager system (BD Biosciences, Rockville, MD).
Montages (2x2) from four adjacent image fields were captured per well in order to
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acquire an adequate number of cells for statistical analysis, utilizing a 10x objective. To
determine the percentage of dead cells from each individual well, both image acquisition
and data analysis were performed using the BD AttoVision v1.6.2 software (BD
Biosciences), and each experimental condition was assessed in triplicate.

2.15. Knockdown of G1
In order to knockdown the expression of G1 in PC12 cells, we employed small
interfering (siRNA) technology. A pool of 4 predesigned siRNAs (ON-TARGET plus
Smart Pool) targeting the gene encoding for rat G1 (GNB1) was obtained from
Dharmacon (Thermo Fisher Scientific, Pittsburgh, PA). The siRNAs were resuspended
in RNase-free water at a stock concentration of 100 μM. PC12 cells were transfected
with DharmaFECT transfection reagent (Dharmacon), following the manufacturer’s
instructions. Briefly, PC12 cells were seeded on 6-well plates at a density of 150,000
cells/well and grown overnight on antibiotic-free media with serum. The following day,
cells were transfected with a mixture of DharmaFECT transfection reagent and different
concentrations of G1 siRNA (50 and 100 nM). Cells were incubated overnight under
normal conditions, and the antibiotic free media was replaced with fresh complete
media. The following day, a second transfection was performed, using the conditions
described above. Three conditions were employed as negative controls: PC12 cells
without any treatment, cells treated with transfection reagent only, and finally, a pool of
siRNAs that do not target any gene in rat cells was employed (non-targeting siRNA,
Dharmacon).
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2.16. Statistical analysis
All statistical analyses were performed using Sigma Plot 11 software (Systat Software,
Chicago, IL, USA). In the case of Western blot quantitative analysis, the differences
between controls and treatments were assessed by means of the Student’s paired ttest. In the case of neurite outgrowth analysis, the differences in various conditions were
assessed by means of one-way ANOVA followed by Holm-Sidak testing (multiple
comparisons vs. control). For comparisons between two groups, the Student’s paired ttest was employed, and in all cases, a value of p < 0.05 was considered to be
statistically significant.
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CHAPTER 3: RESULTS

3.1. Specific Aim 1: Determine if G and its interaction with MTs is important for
neurite outgrowth

3.1.1. Objective and Overview

Dynamic rearrangements of MTs and actin filaments are critical for growth cone
motility and neurite outgrowth. Previous studies from our laboratory have shown that the
 subunit of signal-transducing G proteins promotes MT assembly (Roychowdhury and
Rasenick, 1997; Roychowdhury et al., 2006; Montoya et al., 2007), which may provide a
mechanism for development of axonal processes and neurite outgrowth. Therefore, in
Specific Aim 1, we explored the interaction between G and MTs and its possible role
in neuronal outgrowth and differentiation. PC12 cells as a model cell line and rat brain
primary neurons in culture were used to conduct the study. Overexpression of G was
employed to address whether G is involved in regulating MT assembly. In addition,
the role of G in coordinating MT-actin interactions during neuronal differentiation was
also investigated.
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3.1.2. NGF-induced neuronal differentiation of PC12 cells promotes the
interaction of G with MTs and stimulates MT assembly

Assembly and disassembly of MTs is critical for neurite outgrowth and
differentiation. Previously we have shown that G binds to tubulin and promotes MT
assembly in vitro, and G immunoreactivity was found exclusively in the MT fraction
after assembly in the presence of 12, suggesting a preferential association with MTs
rather than soluble tubulin (Roychowdhury and Rasenick, 1997). In PC12 cells, we
found that G interacts with MTs and is involved in regulating MT assembly (Montoya
et al., 2007).

Because NGF is known to induce neuronal differentiation, we thought that one of
the mechanisms by which NGF induces neuronal differentiation could be via G-MT
interactions and changes in MT assembly. To address this, PC12 cells were treated
with NGF over the course of three days to allow for neuronal differentiation. Cytoskeletal
(CSK, enriched in MTs) and soluble protein fractions (SOL, enriched in dimeric tubulin)
were extracted using MS buffer as indicated in the methods. CSK pellets were
resuspended in PEM buffer, followed by sonication and centrifugation as discussed in
methods. The interaction of G with MTs and tubulin was analyzed by coimmunoprecipitation using a G-specific antibody (rabbit polyclonal anti-G) and by
determining tubulin immunoreactivity (using a mouse monoclonal anti- tubulin) in
immunoprecipitated (IP) and unbound supernatant fractions (SUP). As indicated in
Figure 7A, G was bound preferentially to MTs (CSK fraction) rather than to dimeric
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tubulin (SOL fraction), which is consistent with our previous studies (Roychowdhury and
Rasenick, 1997; Roychowdhury et al., 2006; Montoya et al., 2007). The results show
that the interaction of G with MTs was increased significantly (150%) in NGF-treated
cells (Figure 7A). When immunoprecipitation was performed (control PC12 cells) in the
absence of primary antibody (“No ab”) or non-specific rabbit IgG (“IgG”), tubulin
immunoreactivity was not detected in the immunocomplex (Figure 7B). This validates
the co-immunoprecipitation analysis we have developed to examine tubulinGinteractions. The result also confirms that the immunoprecipitation experiment can
be performed reliably using the CSK fraction employed in our study. The MT assembly
was assessed by determining tubulin immunoreactivity in CSK and SOL fractions and
measuring the ratio of tubulin incorporated in the MTs vs. free tubulin as a direct
measure of MT assembly. We found that MT assembly was stimulated significantly
(from 45.3 ± 4.8% to 70.1 ± 3.6%) in NGF-differentiated PC12 cells (Figure 7C).
Previously, using the anti-microtubule drug nocodazole we have shown that the
interaction of G with MTs is an important determinant for MT assembly. While
microtubule depolymerization by nocodazole inhibited the interactions between MTs
and G, this inhibition was reversed when microtubule assembly was restored by the
removal of nocodazole (Montoya et al., 2007). Therefore, the increased interactions of
G with MTs in response to NGF could account for the stimulation of MT assembly
observed in the presence of NGF (Figure 7A–C). Although it can be argued that MT
structure is no longer intact in CSK fraction subsequent to sonication and low-speed
centrifugation, we have shown earlier that the tubulin dimer binds to G, and that the
tubulin-G complex preferentially associates with MTs (Roychowdhury and Rasenick,
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1997; Roychowdhury et al., 2006). Therefore, the tubulin-G complex is expected to be
present in the CSK fraction prepared in this study. The absence of any interactions
between G and tubulin in SOL fraction despite their presence in SOL fraction further
supports this result (Figure 7A). Furthermore, tubulin oligomers are expected to be
present in the CSK fraction, and the possibility exists that G preferentially binds the
oligomeric structures (Roychowdhury and Rasenick, 1997). The increased interactions
of G with MTs and the stimulation of MT assembly observed in the presence of NGF
could allow for a rearrangement of MTs during neuronal differentiation.
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Figure 7. NGF promotes the interaction of G with MTs and stimulates MT assembly.
PC12 cells were treated with 100 ng/mL of NGF for three consecutive days. Cytoskeletal (CSK)
and soluble protein (SOL) fractions were prepared as described in the methods. Equal amounts
of proteins from each fraction were subjected to immunoblot analysis using anti-tubulin antibody
as indicated (C, top panel) or immunoprecipitation using anti-G antibody followed by
immunoblot analysis of immunoprecipitates (IP) and supernatants (SUP) using anti--tubulin
antibody (A, top panel). Protein bands were detected using the ECL-plus reagent, quantitated,
and expressed as a percent tubulin co-immunoprecipitated with G(A, bottom panel) or as a
percent of tubulin in the CSK fraction (MT assembly) (A, bottom panel). Immunoprecipitation
was also performed (in CSK and SOL from control PC12 cells) in the absence of a primary
antibody (No ab), non-specific rabbit IgG (IgG), or anti-Gantibody followed by immunoblotting
with anti-tubulin (B). A representative experiment is shown. Values shown in the histograms
represent mean ± standard error of three independent experiments done in duplicates. *p
values < 0.05.
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The interaction of G with MTs in NGF-differentiated cells was also assessed by
immunofluorescence microscopy. PC12 cells that were treated with or without NGF
were examined for G and tubulin immunostaining by confocal microscopy. Tubulin was
detected with a monoclonal anti-tubulin (primary antibody) followed by a secondary
antibody (goat-anti-mouse) that was labeled with tetramethyl rhodamine (TMR).
Similarly, G was identified with rabbit polyclonal anti-G followed by FITC-conjugated
secondary antibody (goat-anti-rabbit), and their cellular localizations and colocalizations were recorded by laser-scanning confocal microscopy. In control cells (in
the absence of NGF), Gco-localized with MTs mainly in the perinuclear region
(Figure 8A, a–c; see also enlargement in c'). After NGF treatment, the majority of the
cells displayed neurite formation (Figure 8A, d–f). G was detected in the neurites
(solid arrow, yellow) and in cell bodies (broken arrow, yellow), where they co-localized
with MTs. Interestingly, G was also localized at the tips of the growth cones (Figure
8A, f), where very little tubulin immunoreactivity was observed (green arrowhead). The
enlarged image of the white box in f (Figure 8A, f') indicates co-localization of G with
MTs/tubulin along the neuronal process and in the central portion of the growth cone,
but not at the tip of the growth cones.

In order to quantitatively assess the overall degree of co-localization between
G and MTs/tubulin along the neuronal processes, an entire neuronal process was
delineated as a region of interest (ROI) using a white contour (Figure 8B), and the colocalization scattergram (using ZEN 2009 software) is shown in Figure 8C, where green
(G) and red (tubulin) signals were assigned to the x and y axes, respectively. Each
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pixel is presented as a dot, and pixels with well co-localized signals appear as a scatter
diagonal line. The average Manders’ overlap coefficient (0.91 ± 0.014) suggests a
robust interaction between G and tubulin along the neuronal process. The specificities
of the antibodies are demonstrated in Figure 8D, where the monoclonal anti- tubulin
and the polyclonal anti-G antibodies used for the immunofluorescence studies do not
show any cross reactivity with other proteins in PC12 cells.

44

Fig. 8. G co-localizes with MTs in the neuronal processes in NGF-differentiated PC12
cells. PC12 cells were treated with and without NGF (control). (A) The cells were then fixed and
double labeled with anti-tubulin (red) and anti-Gβ (green) antibodies as indicated in the
methods. Areas of overlay appear yellow. The enlarged image of the white box (c) shows colocalization of G with MTs in the perinuclear region (c'). The white box on the lower panel (f')
shows the enlarged growth cone, with G co-localizing with tubulin along the neuronal process
and in the central portion of the growth cone, while the neuronal tips show predominant G
immunostaining. The solid yellow arrow indicates neuronal processes, and the broken yellow
arrow indicates cell body. The scale bars in “a–c” and “d–f” are 20 µm and 50 µm, respectively.
(B) Co-localization of G with MTs in the neuronal processes was quantitatively assessed
using Zeiss ZEN software. A representative image of a region of interest (neuronal process) of
an NGF-differentiated PC12 cell is shown. (C) A representative scattergram depicting colocalization of G with MTs along the neuronal process is shown. (D) Representative Western
blots (using PC12 whole-cell lysates) showing the specificity of the anti-G (left) and anti-tubulin
(right) antibodies that were used for immunofluorescence.
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3.1.3. Overexpression of Gin PC12 cells induces neurite outgrowth in the
absence of NGF

In order to further delineate the role of G during neurite outgrowth, G was
overexpressed in PC12 cellsSince previous studies indicated that G12 promoted MT
assembly in vitro (Roychowdhury and Rasenick, 1997), PC12 cells were co-transfected
with YFP-tagged 1 and 2 constructs. Cells were either co-transfected with 1 and 2,
or transfected as individual constructs (G1 and G2). A plasmid encoding only YFP
was used as control. Transfected cells were monitored for protein expression and
possible neurite formation at different time points (24 h, 48 h, and 72 h), and both DIC
and fluorescence images of the live cells are shown in Figure 9. We found that within 24
hours of transfection, 12-transfected PC12 cells overexpressed the proteins as
demonstrated by fluorescent (YFP) labeling (Figure 9A, b). DIC images indicated no
changes in morphology (Figure 9A, a). At 48 h of transfection, YFP-12-transfected
cells displayed neurite formation (in the absence of added NGF) (Figure 9B).
Overexpressed protein (YFP-G12) was localized in the neurite processes (long
arrows, white), growth cones (arrowhead, red), and cell bodies (short arrow, white), as
shown by fluorescent (YFP) labeling (Figure 9B, d, f, h). In some cells, clear cytoskeletal
labeling (arrowhead, yellow) was also observed (Figure 9A, h), which suggested
localization of the protein with cytoskeletal filaments. Interestingly, we found that many
of the 12-overexpressing cells had a tendency to divide into two equal halves at the
tips of the neurites (short arrow, yellow) (Figure 9B, g–h). After 72 h, some cells
displayed complex neurite formation (Figure. 9C, i–j, long white arrows), but in many
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cells the tips became enlarged (Figure 9C, k–l, dashed arrows, white), or they showed
multiple, short processes (Figure 9C, m–n, short arrows, red). Control cells
overexpressing only YFP did not induce neurite formation after 48 or 72 h of
transfection (Figure 9D, q–t). The addition of NGF (100 ng/mL) did not have any
additional effect on neurite formation in G-overexpressed cells.

Because both G and G constructs used in the current study were YFP-tagged,
it was not possible to evaluate whether cells that displayed neurites were transfected
with both subunits or not. Therefore, PC12 cells were transfected with individual
constructs (G1 or G2, Figure10). We found that the cells transfected with either G1
or G2 induced neurite outgrowth (figure not shown), although the neurites appeared to
be less defined and the fluorescence intensity (YFP) was found to be lower than that
observed in G12 transfected cells (using the same microscope settings). As indicated
in Figure 11, the average neurite length was also less than that observed in the
presence of G12 overexpression.
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Fig. 9. Overexpression of G induces neurite outgrowth in PC12 cells. PC12 cells were
co-transfected with YFP-tagged constructs encoding G1 and G2 (12) in the absence of
NGF, using Lipofectamine LTX PLUS reagent according to manufacturer instructions. Cells
overexpressing fluorescent proteins were monitored at different time points for protein
expression and morphological changes using a fluorescence microscope: 24 h (A), 48 h (B),
and 72 h (C). PC12 cells transfected with a plasmid-encoding YFP only was used as control (D)
and were observed through the same time points. Images taken with DIC and YFP filters are
shown. Neuronal processes, long white arrows; cell bodies, short white arrows; growth cones,
red arrowheads; axonal branching, short yellow arrow; cytoskeletal labeling, yellow arrowhead;
enlarged and bulky neurites, dashed white arrows; and multiple short processes, short red
arrows. Scale bars: 50 µm in b, j, l, n, p, r, t; and 40 µm in d, f, h.
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Figure 10. Transfection of PC12 cells with individual constructs (G or G2). PC12 cells
were transfected with individual YFP-tagged constructs encoding G1 (A) or G2 (B). Cells were
then monitored for protein expression and changes in morphology at different time points as
indicated in the figure. DIC and YFP images are shown. Scale bars: 50 µm. Neuronal
processes, long white arrows; cell bodies, short white arrows; axonal branching, short yellow
arrow; enlarged and bulky neurites, dashed white arrows; multiple short processes, short red
arrows.
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Measurement of the number and length of neurites provides a quantitative
assessment of neuronal differentiation (Harrill and Mundy, 2011). Therefore, in order to
assess the effect of G overexpression on neuronal differentiation of PC12 cells, a
quantitative assessment of neurite outgrowth was conducted by measuring two different
parameters, average neurite length, as well as the percentage of cells bearing neurites,
in G-, G-, or G-overexpressing cells (Figure 11A and B). Cells co-transfected
with G1 and G2 (42.8 ± 2.1 m) displayed neurites that were, on average, significantly
longer than those of control cells (18.4 ± 0.6 m) and those of cells overexpressing only
G1 or only G subunits (Figure 11A). Although the average neurite length in Goverexpressing cells (42.8 ± 2.1 m) was slightly lower than that observed in NGFdifferentiated PC12 cells (53.6 ± 1.8 m), the result clearly indicates the effectiveness of
G in inducing neurite outgrowth. We also evaluated the percentage of cells bearing at
least one neurite in each condition. We found that ~25% of the G12-overexpressing
cells induced at least one neurite (Figure 11B). A cell was considered neurite-bearing if
it contained at least one neuronal process that was longer than the cell body (15.6 ± 0.5
µm in diameter).
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Figure 11. Quantitative assessment of neurite outgrowth in PC12 cells overexpressing of
G1, G2, or G12. PC12 cells overexpressing G were fixed and processed for confocal
microscopy using anti-tubulin antibody. (A) The average neurite length of G-, G-, or Goverexpressing PC12 cells is shown. *p value < 0.05; **p value < 0.001. (B) The percentage of
cells bearing neurites in transfected cells was also estimated. *p value < 0.05; **p value < 0.005;
***p value < 0.001.
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3.1.4. 3D image analysis of PC12 cells overexpressing G shows co-localization
of overexpressed protein with MTs

To test the localization and association of overexpressed G (YFP-G1with
MTs, cells overexpressing G (48 h) were fixed and processed for confocal microscopy
(Fig. 12), as was done previously with NGF-differentiated cells. Tubulin was detected
with a monoclonal mouse anti-tubulin antibody followed by a secondary antibody (goat
anti-mouse) that was labeled with tetramethyl rhodamine. G and MTs were visualized
with high-resolution 3-D reconstructions of confocal image stacks using Volocity 3-D
Image Analysis Software. Rotations performed on the deconvolved 3-D reconstruction
within the software’s graphical user interface allowed the transfected PC12 cells to be
viewed from any direction for a more complete picture of the neuronal processes. The
localization of G in neuronal processes and its association with MTs were clearly
visible by panning, zooming into, and rotating the 3-D images. Bookmarking the time
points at which we performed these translations of the reconstruction allowed for
capture within a motion picture format (Movie 1, Supplementary Material), and for still
frames from this movie to be extracted (Figure 12). MT filaments (red; Figure 12A, left
panel, and Figure 12B, Frame 819) and G (green; Figure 12A, middle panel, and
Figure 12B, Frame 819) interact throughout the neuronal process, as evidenced by
clear yellow labeling (Figure 12B, Frame 866). G labeling (green) was also observed
from all directions to be alongside yellow labeling throughout the neuronal process
(Figure 12B, Frames 499, 669, 786, 819, and 866). In some areas, red labeling was
also clearly visible. This labeling pattern appears to support our in vitro results, which
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indicate that G binds on the microtubule wall when promoting MT assembly
(Roychowdhury and Rasenick, 1997). These results are consistent with the possibilities
that the yellow labeling we observe in neurites marks domains on G that interact with
MT filaments and that the green labeling represents G domains that are not
interacting directly with MTs but are projecting from MT walls. These possibilities
notwithstanding, it is reasonable to suggest on the basis of this unique labeling pattern
as well as previous in vitro results (Roychowdhury and Rasenick, 1997) that G
induces neurite outgrowth through its ability to interact with tubulin/MTs and stimulate
MT assembly.
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Figure 12. 3-D view of co-localization of G and microtubules (MTs). Co-localization of
overexpressed Ggreen) with MTs (red) as visualized by high-resolution 3-D confocal images
using Volocity software (see Methods). The images shown in this assembly are still frames from
Supplementary movie 1 (Supplementary materials). (A) A still frame from the movie separated
into its component channels: MT (red) and Ggreen) expression are each confined discretely
to similar subcellular locations as shown in the merged panel (yellow). (B) Representative still
frames were selected to summarize the content of the movie. The numbers on the top right of
each still image denote the frame numbers within the movie. Arrows in frame 819 correspond to
MT expression (red, top arrow) and Ggreen, bottom arrow) expression. The arrow in frame
866 points to co-localization of MT and Gyellow). The edges of each individual square in the
background grid for each image are 19.21 m in length.
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3.1.5. G interacts with MTs in hippocampal and cerebellum neurons in cultures
from rat brain

Although PC12 cells have been used extensively to study the mechanism of
neuronal outgrowth and differentiation, neurons are more complex and give rise to a
“dendritic tree” and an axon that may branch hundreds of times before it terminates.
The axon terminal contains synapses, which are specialized structures that release
neurotransmitters in order to communicate with target neurons. Thus, neurons are
capable of interacting with one another to form the complex neuronal networks
necessary for the processing and transmission of cellular signals. To precisely identify
the role of G-MTs interactions in neuronal morphology and functioning, it is important
to demonstrate whether or not this interaction occurs in neurons. Therefore, as a first
step we established neuronal primary cultures from newborn rat brains, specifically from
the cerebellum and hippocampus. These brain regions were selected because they
have been extensively validated as cell-culture models for studying the role of the
cytoskeleton in neuronal polarity and axonal development (Dotti et al., 1988; Powell et
al., 1997; Tahirovic and Bradke, 2009). In addition, these two brain regions are
associated with different functions. While the hippocampus is involved in memory
formation and neural plasticity, the cerebellum is primarily responsible for motor control,
posture, and balance (Purves et al., 2008; Koehl and Abrous, 2011).

As described for PC12 cells, confocal microscopy, subcellular fractionation, and
co-immunoprecipitation

analysis

were
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performed

to

determine

the

co-

localization/interactions of G with MTs in hippocampal and cerebellar neurons. We
found that G co-localizes very intensely with MTs in the neuronal processes in
hippocampal neurons (Figure 13A, panels c and c'). Co-immunoprecipitation analysis
using CSK and SOL fractions indicates that G interacts with both MTs and soluble
tubulin (Figure. 13B). In cerebellar neurons, both confocal microscopy (Figure 13C) and
co-immunoprecipitation analyses (Figure 13D) indicate a weak association of G with
MTs. Since G appears to interact with MTs/tubulin preferentially in hippocampal
neurons, it is possible that G could be involved in regulating neurite outgrowth and
synapse formation by modulating MT assembly in hippocampal neurons.
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Figure 13. G interacts with MTs in primary hippocampal and cerebellar neurons.
Neuronal primary cultures from rat brain hippocampus and cerebellum were prepared as
described in section 2.13. Hippocampal and cerebellar neurons were then either processed for
confocal microscopy (A, C) or subcellular fractionation followed by co-immunoprecipitation
analysis (B, D). The enlarged view of the white boxes (c', f') depicts G-tubulin co-localization
in the neuronal process in hippocampal and cerebellar neurons. The scale bar is 20 µm. CSK
and SOL fractions from hippocampal and cerebellum neurons were subjected to coimmunoprecipitation using anti-G antibody or no antibody (No ab) followed by immunoblotting
using anti-tubulin (B, D) antibody.
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3.1.6. G interacts with actin filaments, and this interaction increases during
neuronal differentiation

In addition to MTs, neuronal outgrowth is also dependent on actin filaments.
Interactions between these two cytoskeletal filaments are also important for growthcone motility and neurite outgrowth (Griffith and Pollard, 1982; Witte and Bradke, 2008;
Geraldo and Gordon-Weeks, 2009). Moreover, axon branching, which requires the
interactions between MTs and actin filaments (Griffith and Pollard, 1982), was observed
in G-overexpressing PC12 cells (Figure 9, g-h), suggesting a possible involvement of
G in MT-actin filaments coupling. Therefore, we investigated whether G, in addition
to MTs, also interacts with actin filaments.

The experimental strategy was similar to that employed to study the interaction of
G with MTs, using confocal microscopy, co-immunoprecipitation, and immunoblotting.
Our results indicate G was localized at the tips of neuronal processes/growth cones in
both G-overexpressing and NGF-differentiated PC12 cells (Figure 8c' and 8f'), where
actin filaments are also known to be localized and form filopodia and lamellipodia. Using
triple immunofluorescence labeling and confocal microscopy, we assessed the colocalization among G, MTs, and actin filaments (Figure 14A, a–f). Tubulin and G
were labeled as previously indicated, and actin was labeled with goat polyclonal antiactin followed by an Alexa Fluor 350-conjugated donkey anti-goat secondary antibody.
We found that in NGF-treated cells, G (green, a) was found in cellular processes
induced by NGF (white arrows), where it co-localized with tubulin (red, b) and actin58

containing structures (blue, c). However, as anticipated, at the tips of these processes,
G (green arrowheads), as well as actin labeling (blue) was observed where they colocalized (e). The co-localization is clearly visible in the enlarged images of the white
box (Figure 14A, d', e', and f').

We also investigated whether G interacts with actin filaments using coimmunoprecipitation analysis. CSK and SOL fractions were isolated, as shown in Figure
14. Unlike tubulin, G was found to interact with both AFs (CSK) and actin monomers
(SOL) (Figure 14B). However, the interaction of G with AFs (but not actin monomers)
increased by ~100%, from 25 ± 3.3% in control cells, to 52.4 ± 10.1% after NGF
treatment (Figure 14C). Actin polymerization was not affected significantly after NGF
treatment (figure not shown). The possibility that G interacts with actin filaments
through MTs was ruled out by the observation that the interactions of G with AFs were
not inhibited by the MT depolymerizing drug, nocodazole (Figure 14D). In fact, G
interactions with AFs increased from ~25% to 35% in the presence of 10-M
nocodazole.
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Figure 14. G interacts with actin filaments in NGF-differentiated PC12 cells. A) NGFtreated PC12 cells were labeled with anti-G (green), anti-tubulin (red), and anti-actin (blue)
primary antibodies (A, upper panel, a-c) as previously described. Co-localization patterns are
shown in the lower panel (d-e). Insets in the lower panel show co-localization patterns at the tip
of neuronal process (d'-f)'. B) PC12 cells were treated with NGF for 3 days and subjected to
fractionation (CSK and SOL), followed by immunoprecipitation with anti-G antibody and
immunoblotting against actin. C) The interaction of G with actin is shown in the graphic and it
is expressed as percent actin co-immunoprecipitated with G in the presence and absence of
NGF. *p value < 0.05. D) PC12 cells were treated with 10 μM nocodazole for 4 hours, and
whole cell lysates were prepared and subjected to co-immunoprecipitation using G antibody.
The histogram shows percent actin co-immunoprecipitated with G in the presence and
absence of nocodazole.
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3.1.7. G interacts with actin filaments in neuronal primary cultures of rat brain
hippocampus and cerebellum

The interaction of G with AFs in primary cultures from hippocampal and
cerebellar

neurons

was

also

studied,

using

subcellular

fractionation,

co-

immunoprecipitation, and confocal microscopy. Confocal microscopic analysis indicated
co-localization of G with actin filaments in cell bodies and neuronal processes both in
hippocampal and cerebellar neurons (Figure 15E and G). In hippocampal neurons, G
was found to interact with actin in the CSK fraction, while no G-actin interaction was
detected in the SOL fraction, suggesting a preferential association of G with
polymerized actin. In cerebellar neurons, G was found to interact with both AF and
actin monomers (Figure 15H).
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Figure 15. G interacts with actin filaments in hippocampal and cerebellar neurons.
Neuronal primary cultures from rat brain hippocampus and cerebellum were prepared as
described in section 2.13. Hippocampal and cerebellar neurons were then either processed for
confocal microscopy (A, C) or subcellular fractionation followed by co-immunoprecipitation
analysis (B, D). The scale bar is 20 µm. CSK and SOL fractions from hippocampal and
cerebellum neurons were subjected to co-immunoprecipitation using anti-G antibody or no
antibody (No ab) followed by immunoblotting using anti-actin (A, C) antibody.
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3.2. Specific Aim 2: Determine if blocking the interactions between G and MTs
alters MT organization and inhibits neurite outgrowth

3.2.1. Objective and Overview

Since the molecular pathways leading to neurodegeneration are not well
understood, and given that no effective drugs against neurodegenerative diseases are
currently available, the goal of this aim was to understand whether blocking the G-MT
interaction can disrupt neuronal differentiation and trigger an early stage of
neurodegeneration by altering MT assembly in neuronal cells. Two experimental
strategies were used to address this specific aim. First, we used a G-sequestering
peptide (GRK2i), in order to shut down G-mediated signaling. Second, we employed
PMPMEase inhibitors developed by our collaborator (Dr. N. Lamango, Florida A&M
University). PMPMEase is a critical enzyme in the protein prenylation pathway, and
these inhibitors were used in an attempt to target the prenylation and further carboxyterminal processing by methylation of the  subunit of G, since this modification has
previously been shown to be critical for its interaction with MTs. PC12 cells,
hippocampal neurons in culture, and SH-SY5Y cells were used as cell models for our
studies.
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3.2.2. GRK2i, a G-sequestering peptide, disrupts MT organization and inhibits
neurite outgrowth

In an attempt to block the G-MT interaction, and to better understand the role
of G in MT organization and neurite outgrowth, we used a synthetic G protein-coupled
receptor kinase 2 (GRK2) inhibitory peptide, known as GRK2i. Gis known to
modulate the activity of several signal-transducing effector molecules, including GRK2
(Claing et al., 2002). GRK2i corresponds to the G-binding domain of GRK2 and
selectively prevents G-mediated signaling and has therefore been used as a valuable
tool for understanding G-dependent functions (Koch et al., 1994; Lodowski et al.,
2003). As indicated in Figure 16A (e–h), in the presence of 5 μM GRK2i, neurite
damage (enlarged images f', g', and h'), as well as MTs and G aggregation (enlarged
images f'', g'', h''), was observed. In addition, cellular aggregation was also frequently
observed in the presence of GRK2i. Images shown here were taken after 60 min of
incubation with GRK2i. GRK2i at 1 M did not have any significant effect on neuronal
differentiation (images not shown).

The effect of GRK2i on neuronal differentiation, neurite outgrowth was
quantitatively assessed by measuring average neurite lengths as well as the percentage
of cells bearing neurites (Figure 16B and C). A cell was considered as neurite-bearing if
it contained at least one neuronal process that was longer than the cell body (13.7 ± 0.5
µm in diameter). As indicated in Figure 16B and C, the percentage of cells bearing
neurites was reduced significantly, from 38.1 ± 3.1% in control cells to 22.8 ± 3.1% after
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30 min of incubation with GRK2i, and did not reduce further after 60 min of incubation.
The average neurite length of surviving neurites decreased modestly in the presence of
GRK2i and increasing the incubation time from 10 min to 60 min did not have any
additional effect, suggesting that NGF-induced neurites are not equally susceptible to
G sequestration.
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Figure 16. GRK2i, a G-blocking peptide, disrupts MT and G organization and inhibits
neurite outgrowth. PC12 cells were treated with 100 ng/mL of NGF for two consecutive days.
Subsequently, 5 µM GRK2i was added to the media, and the cells were incubated for 10, 30,
and 60 min. The cells were then fixed and double labeled with anti-tubulin (red) and anti-Gβ
(green) antibodies, and processed for confocal microscopy. DAPI was used for nuclear staining
(blue). (A) Control cells exhibit typical morphology, displaying multiple long neurites. G is
shown to co-localize with tubulin/MTs along the neurites (solid yellow arrow) but not at the tip of
the neurites (green arrowheads), where G immunostaining is predominant. Inhibition of G
signaling by incubation with GRK2i causes neurite damage, microtubule disruption, and alters
the G-tubulin co-localization pattern, as shown in the enlarged images in the white boxes (f'–
h', and f''–h''). Scale bars are 20 µm. (B–C) PC12 cells were treated with NGF and GRK2i as
described above, followed by fixing and processing for confocal microscopy as described
previously. Using Zeiss ZEN software, neurites were traced and measured, and average neurite
length and percent of cells bearing neurites were determined. Differences between experimental
conditions were assessed by one-way ANOVA. *p < 0.05; **p < 0.01.
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3.2.3. Inhibitors of PMPMEase disrupt MTs and G organization and inhibit
neurite outgrowth of NGF-differentiated PC12 cells

In order to determine whether PMPMEase may play a regulatory role in the Gdependent regulation of MTs and neurite outgrowth, we used two PMPMEase inhibitors
(L-23 and L-28) in this study to determine whether this enzyme may play a regulatory
role in the G-dependent regulation of MTs and neurite outgrowth. PC12 cells were
treated with the PMPMEase inhibitors (L-23, L-28, or the prototypical molecule PMSF),
and then allowed to differentiate in the presence of NGF for two consecutive days. At 1M concentration, the inhibitors did not have any noticeable effect on neurite outgrowth,
while both 5- and 10-M inhibitors did affect neurite outgrowth (Figure 17). As indicated
in the figure, while neuronal outgrowth was not affected by PMSF (10 M) (Figure 17A,
a–d), both L-23 and L-28 had significant effects on neuronal differentiation, as indicated
by axonal damage (Figure 17A, e–h; see the enlarged image in the box), and on
inhibition of neurite outgrowth (Figure 17A, i–l), which altered the MTs and G
organization. Cellular aggregation was also evident in the presence of 10 M L-23 and
L-28. As indicated in Figure 17A, m–p, Gwas concentrated in the cell-cell contact
region (clearly visible in the enlarged box) in the presence of 10 M L-28 and could be
responsible for mediating cellular aggregation.

The effects of L-23 and L-28 on neuronal outgrowth were also assessed
quantitatively by measuring average neurite lengths as well as the percentage of cells
bearing neurites as was done previously in the presence of GRK2i. As indicated in
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Figure 17B and C, the percentage of cells bearing neurites was reduced significantly in
the presence of 5 or 10 M L-23 and L-28, with L-28 at 10 M being the most potent.
The average neurite length of surviving neurites was also modestly decreased in the
presence of L-23 and L-28. Once again, L-28 at 10 M appeared to be the most potent
in inhibiting neurite outgrowth. The result indicates that a population of NGFdifferentiated cells is not affected by PMPMEase inhibitors.
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Figure 17. PMPMEase inhibitors disrupt neurite outgrowth of NGF-differentiated PC12
cells. PC12 cells were treated with PMPMEase inhibitors, L-23 (5 M), and L-28 (5 M, and 10
M), or the prototypical molecule PMSF (10 M) and allowed to differentiate in the presence of
100 ng/mL of NGF for two consecutive days. (A) Cells were then fixed and double labeled with
anti-tubulin (red) and anti-Gβ (green) antibodies, and DAPI was used for nuclear staining (blue).
Co-localization patterns are also shown in the merged images. PMSF did not seem to have any
significant effects on neuronal morphology (a–d). PMPMEase inhibitors inhibited neurite
outgrowth of NGF-treated PC12 cells, causing axonal damage (e–h, enlarged image shown in
h'), neurite shortening (i–l, enlarged image shown in l'), and cellular aggregation (m–p). Scale
bars are 20 µm (B–C). Using Zeiss ZEN software, neurites were traced and measured, and the
average neurite length and percent of cells bearing neurites were estimated. The differences
between experimental conditions were assessed by one-way ANOVA. *p < 0.05; **p < 0.01.
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3.2.4. Inhibitors of PMPMEase and GRK2i peptide do not cause cell death in PC12
cells

To determine if the GRK2i peptide or PMPMEase inhibitors L-23 or L-28 induced
neuronal cell death at the concentrations used, a previously described differential
nuclear staining (DNS) assay (Lema et al., 2011) was performed as described in section
2.14. Briefly, PC12 cells were grown on 96-well plates and incubated with NGF and
inhibitors as indicated, followed by 1 h incubation with a mixture of Hoechst/propidium
iodide (PI). Hoechst has the ability to cross cell membranes of both healthy and dead
cells and to stain nuclear DNA, thus providing the total number of cells, whereas PI is
only able to stain cells having a loss of plasma-membrane integrity, thus denoting the
number of dead cells. Subsequently, cells were imaged in live mode using a BD
Pathway 855 Bioimager system as described in the methods section. Representative
images corresponding to the same section of 2 x 2 image montages from several
conditions (a–l) are shown (Figure 18A). The percentage of dead cells in the presence
of inhibitors was determined by using the BD AttoVision v1.6.2 software (BD
Biosciences), and the result was plotted as shown in Fig. 18B and C. As indicated in the
figure, GRK2i did not cause cytotoxicity on NGF-differentiated PC12 cells. In the case of
the PMPMEase inhibitors L-23 and L28, no significant cell death was detected at the
tested concentrations. The prototypical compound, PMSF, was also assayed and not
found to be cytotoxic. Hydrogen peroxide (100 M) was used as a positive control.
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Figure 18. Inhibitors of PMPMEase and GRK2i do not induce neuronal cell death. PC12
cells were grown on 96-well plates and treated with NGF and inhibitors as indicated in methods.
Subsequently, cells were incubated with a Hoechst/PI mixture for DNS cytotoxicity assay. The
images were captured in live-cell-image mode using the confocal automated microscope BD
Pathway Bioimager system and a 10x objective, assisted with AttoVision software. (A)
Representative images corresponding to the same section of 2 x 2 image montages from
several conditions (a–l) are shown. H2O2 (100 µM) was used as a positive control. Cell nuclei
stained with Hoechst provided the total number of cells; cell nuclei stained with PI indicate the
number of dead cells; merged Hoechst and PI images indicate the number of dead cells in the
image. (B-C) Cell death was plotted as the percent of PI-positive cells, denoting the total
number of dead cells for each condition.
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3.2.5. Inhibition of PMPMEase blocks the interaction of G with MTs and induces
degeneration of SH-SY5Y neuroblastoma cells

The effect of inhibitors of PMPMEase was also tested in human neuroblastoma
SH-SY5Y cells, a cell line that has been used as a model to study neuronal
differentiation and function (Xie et al., 2010). Both confocal microscopic analysis and
co-immunoprecipitation was performed to conduct the study.

For confocal microscopic analysis, SH-SY5Y cells were attached to chambered
slide and treated with DMSO, PMSF (100 μM), L-23 (100 μM), or L-28 (10 μM) for 24
hours. The slides were then fixed and processed for confocal microscopy as described
before. Cells were immunolabeled for MTs (red) and G (green), and DAPI was used
for nuclear staining. As shown on Figure 19A (a-d), control cells (treated with DMSO)
displayed typical morphology, with many cells forming neurites (white arrows), and
depicting G co-localizing with MTs along these processes. The prototypical molecule,
PMSF (100 μM), does not seem have dramatic effects on cell morphology, as cells still
display neurites (Figure 19A, white arrows, e-h). Cells treated with 100 μM L-23 did not
seem to cause significant effects, although cells appear to be more aggregated than
control and PMSF-treated cells (Figure 19A, i-l). In the presence of L-28 (10 μM),
significant cellular damage was evident. Cellular aggregation was very prominent, and
neurites seem to be completely disrupted. Localization and co-localization of G and
MTs was also affected (Figure 19A, m-p).
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To test whether inhibition of PMPMEase activity alters the interaction of Gwith
MTs, SH-SY5Y cells were treated with 5 µM L-28 for 24 h followed by subcellular
fractionation. We found that L-28 completely abolished the interaction of G with MTs
(CSK fraction), as demonstrated by co-immunoprecipitation analysis (Figure 19B and
C). As found earlier, G did not form a complex with tubulin dimer (SOL fraction), and
L-28 did not alter this (figure not shown). Thus, it appears that blocking the prenylation
and carboxy-methylation of G in SH-SY5Y cells disrupted the G-MT interaction,
supporting a critical role of G prenylation in the regulation of MT assembly, as
previously suggested by in vitro findings (Roychowdhury and Rasenick, 1997). Taken
together, the biochemical and confocal microscopy results indicate that inhibition of
PMPMEase blocks the interaction of G with MTs, disrupting cellular morphology and
inducing neurodegeneration of SH-SY5Y cells.
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Figure 19. Inhibitors of PMPMEase block the interaction of G with MTs and cause G
and MT disruption, and cellular aggregation of SHSY5Y neuroblastoma cells. (A) SHSY5Y cells were treated with PMPMEase inhibitors as indicated, and fixed and processed for
confocal microscopy. G and MTs were detected with FITC (green) and TMR (red) secondary
antibodies, and DAPI was employed for nuclear staining. Co-localization patterns are shown in
the merged images. Arrows indicate the presence of neurites. Scale bars in d, h, l, and p are 20
µm. (B-C) SH-SY5Y cells were treated with L-28 (5 µM for 24 h), and CSK and SOL fractions
were prepared. CSK fractions were subjected to co-immunoprecipitation using anti-G antibody,
followed by immunoblotting of IP and SUP samples with anti-tubulin antibody (left panel). The
interaction of G with MTs is expressed as percent tubulin co-immunoprecipitated with G in
the CSK fraction (right panel).
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3.2.6. PMPMEase inhibitors cause neurite damage and alter the G/MT
organization in hippocampal neurons

While PC12 and SH-SY5Y cells are two widely used and validated models to
study neuronal differentiation, function, and degeneration, these cells do not possess
the entire set of features that characterize neuronal cells. Thus, the effect of
PMPMEase inhibitors was tested primary cultures from rat brain hippocampus. Fully
differentiated hippocampal primary neurons (7 days in culture) were treated with
inhibitors (L-23 and L-28) and subjected to immunoflorescence labeling and confocal
microscopic examination. Control cells display typical neuronal morphology, with long
axonal processes extending from the cell body (Figure 20, a-c). G localizes both in
the cell body and neurites, where it co-localizes with MTs (see enlarged box, c'). In L-23
and L-28 treated cells, the overall cellular integrity was affected (Figure 20, d-i).
Damage to the neurites was evident, and alteration of the G/MTs co-localization was
observed. Cells treated with L-23 and L-28 (see enlarged boxes, f' and i') exhibited
aggregation of proteins along the neurites, suggesting cytoskeletal damage, which
could also be an indicator of degeneration of hippocampal neurons.
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Figure 20. L-23 and L-28 disrupt neuronal cell morphology and alter MTs/G
localization/co-localization

in

hippocampal

primary

neurons.

Primary

cultures

of

hippocampal neurons were prepared from brains of postnatal day (1-2) Sprague Dawley rats.
Neurons were seeded on pre-coated glass coverslips and used for immunofluorescence
labeling and confocal microscopy. The localization of microtubules (mouse monoclonal anti-
tubulin, red) and G (rabbit polyclonal anti-G, green) was visualized by confocal microscopy.
Primary neurons were kept in culture for 7 days (to allow full neuronal differentiation) and then
treated for 24 hours with either DMSO (controls), 5 µM L23, and 5 µM L28.
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3.2.7. Knockdown of G1 using siRNA appears to affect the cellular levels of
tubulin

In a further attempt to disrupt the G-MT interaction, we used siRNA technology
to knockdown the expression of G PC12 cells. Since previous studies from our
laboratory demonstrated that G12 binds to MTs and promotes MT assembly, we
targeted the specific G1 isoform for knockdown. Given that PC12 cells are derived
from rat, the siRNAs were specifically designed to target rat G1. Cells were transfected
with a pre-designed pool of siRNAs, and the knockdown was assessed by
immunoblotting.

The results show that two concentrations of siRNA (50 and 100 nM) were
effective in completely abolishing G1 expression (Figure 21). When the total levels of
G were assessed, no significant decrease in protein expression was detected.
Interestingly, the levels of tubulin appear to be affected by the knockdown of G, since
we found that tubulin expression seems to decrease after transfection of PC12 cells
with 100 nM G1 siRNA. This result further supports the notion that G is a critical
player in the regulation of the MT cytoskeleton. The levels of actin, another cytoskeletal
protein, do not appear to be affected by knockdown of G1. The cytosolic protein
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used as a control to verify
sample loading. A non-targeting pool of siRNAs was employed as a negative control,
and it does not have any effect on protein expression, thus validating the knockdown
experiment.
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Figure 21. Knockdown of G1 using siRNA in PC12 cells. PC12 cells were transfected with
two concentration of a pool of siRNAs targeting the rat G1. Negative controls were included
(untreated cells, transfection reagent, and non-targeting siRNA) to validate the knockdown of
G1. Cells were subsequently lysed and subjected to imunoblotting against different antibodies
as indicated.
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3.3. Specific Aim 3: Determine the signaling pathways involved in G-dependent
regulation of MT assembly and neurite outgrowth

3.3.1. Objective and Overview

The goal of this aim was to identify the signaling pathway by which Gregulates
the MT cytoskeleton and neurite outgrowth. Both receptor tyrosine kinase TrkA and G
protein-coupled receptor (GPCR) pathways appear to play key roles in this process.
However, the mechanism by which these two pathways coordinate to regulate
assembly/organization of MTs during neurite outgrowth is not well understood. PI3K
signaling emerged as an important pathway downstream to TrkA that regulates
cytoskeletal rearrangement in neurons (Cantley, 2002; Zhou et al., 2004). Since PI3K is
also a downstream effector of G in GPCR signaling, and recent results suggest that
the activation of PI3K/Akt pathway by NGF is in part mediated through the  subunit
(Wu and Wong, 2005; Wang and Wong, 2009), we hypothesized that G, in
association with PI3K, coordinates the signals from TrkA and GPCR to regulate MT
cytoskeleton and neurite outgrowth.

Therefore, in Specific Aim 3, we investigated the dynamic interactions between
G and PI3K signaling, and their roles in regulating MT assembly and neurite
outgrowth. Both PC12 cells and neuronal primary cultures from rat brains were used for
these studies.
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3.3.2. Gallein, as well as PI3K inhibitors, promotes neurite outgrowth of NGFdifferentiated PC12 cells, but does not alter levels of MT assembly

To understand the role of PI3K in modulating G-dependent regulation of MT
assembly and neurite outgrowth, we used gallein, a small molecule known to bind to
G and inhibit G-dependent activation of PI3K- (Lehmann et al., 2008). In addition
to gallein, we also used two well-established PI3K inhibitors, wortmannin and
LY294002. Both confocal microscopic analysis and subcellular fractionation were
carried out to determine if PI3K is involved in G-dependent regulation of MT assembly
and neurite outgrowth. For confocal microscopic analysis, PC12 cells were seeded in
immunocytochemistry chamber slides and allowed to differentiate in the presence of
NGF (three consecutive days), followed by treatment with 10 μM gallein (30 min.), 0.2
μM wortmannin (1 h), or 100 μM LY294002 (1 h). The concentrations and time of
incubation with the inhibitors were chosen based on their use in the literature.
Subsequently, cells were fixed and processed for confocal microscopy, using G and
tubulin specific antibodies, and FITC- and TMR-conjugated secondary antibodies. We
used laser-scanning confocal microscopy to examine the cells. Control cells were found
to display typical morphology with neurites extending from the cell body. G-tubulin colocalization can be observed along the neurites, except at the neuronal tips, where
predominant G immunostaining is found (Figure 22A, a-c). Cells treated with inhibitors
(Figure 22A, d-l) do not seem to display significant changes in morphology and the colocalization patterns between G and MTs were similar to those observed in control
cells. However, neurites appeared to be longer in the presence of all three inhibitors.
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Therefore, we used the 2009 Zen software to trace and measure the neurites in order to
obtain a quantitative assessment of neurite length after treatment with inhibitors. We
found that the average neurite length was increased from 47.7 ± 2.7 μm in control cells,
to 61.9 ± 3.1 μm, 63.2 ± 4.7 μm, and 59.5 ± 4.6 μm in gallein-, wortmannin-, and
LY294002-treated cells, respectively. The percent of cells bearing neurites was also
determined (Fig. 22C), but no significant differences were observed between controls
and cells treated with inhibitors. The result suggests that the inhibition of PI3K activity
favors G-MT interactions and neurite outgrowth. Since gallein binds to G and blocks
G-dependent activation of PI3K-, the data also suggests that G and PI3K may
work in concert to regulate neuronal outgrowth and differentiation.

To assess the possible changes in MT assembly after inhibition of PI3K, PC12
cells were seeded in 100 mm plates and allowed to differentiate in the presence of
NGF, followed by treatment with inhibitors as indicated in the figure (Figure 23).
Subsequently, cells were fractionated into CSK and SOL fractions as indicated in the
methods, and MT assembly was assessed by determining tubulin immunoreactivity in
both fractions. We found that gallein or PI3K inhibitors did not alter the level of MT
assembly in NGF-differentiated PC12 cells (Figure 23A). Although average neurite
length increased modestly in the presence of gallein or PI3K inhibitors, this effect may
not be sufficient to alter MT/ST equilibrium in cells. In addition, NGF has been shown to
increase the levels of MT assembly by ~70% (Section 3.1.2, Figure 7C), therefore
making it difficult to assess any differences in MT assembly that may have been caused
by the inhibitors.
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Figure 22. Gallein and PI3K inhibitors promote neurite outgrowth of NGF-differentiated
PC12 cells. PC12 cells were induced to differentiate by treatment with NGF for three
consecutive days. Cells were then treated with or without gallein (10 µM for 30 min.),
wortmannin (0.2 µM for 1 h), and LY294002 (100 µM for 1 h). A) Cells were fixed and processed
for confocal microscopy. G was detected with FITC (green), and tubulin/MTs was detected
with TMR (red). Scale bars are 20 μm. B) Using the Zen software, neurites were traced and
measured, and average neurite length was calculated. *p value < 0.05. C) Percent cells bearing
neurites was also determined.
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Figure 23. PI3K inhibitors do not affect MT assembly in NGF-differentiated PC12 cells.
PC12 cells were induced to differentiate by incubation with NGF for three consecutive days.
This was followed by treatment with or without gallein (10 µM for 30 min.), wortmannin (0.2 µM
for 1 h), and LY294002 (100 µM for 1 h). CSK and SOL fractions were then prepared and
subjected to the following: (A) CSK fractions were subjected to western blotting using an antitubulin antibody as indicated in the methods. MT assembly was determined by assessing
tubulin immunoreactivity in both fractions, and it is expressed as percent tubulin in CSK fraction;
and (B) immunoblotting using G antibody to determine the percent G in CSK fraction.
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3.3.3. Gallein and PI3K inhibitors stimulate MT assembly and promote the
interactions of G with MTs in undifferentiated PC12 cells (without NGF)

Since we were unable to detect any differences in MT assembly in NGFdifferentiated PC12 cells in the presence of gallein or PI3K inhibitors, we decided to use
undifferentiated PC12 cells, given that the basal levels of MT assembly are lower in
PC12 cells in the absence of NGF and therefore could allow us to observe changes in
MT assembly in the presence of the inhibitors. In addition to MT assembly, the effect of
inhibitors on MT-G interaction was also determined.

We found that MT assembly was significantly increased in PC12 cells after
treatment with all three molecules under study (Figure 24A). Treatment with gallein
increased MT assembly from 17.5 ± 2.5% to 32.1 ± 0.89%. However, more significant
increases in MT assembly were seen in the presence of wortmannin and LY294002, as
we found that they stimulated MT assembly to 63.08 ± 1.97% and 65.6 ± 2.36%,
respectively. We also found that treatment with PI3K inhibitors significantly promoted
the interaction of G with MTs (CSK fraction) by ~100%, as demonstrated by coimmunoprecipitation analysis (Figure 24B and C). As found before (Section 3.1.2,
Figure 7A) tubulin did not form a complex with G in the SOL fraction, and the PI3K
inhibitors did not alter this (figure not shown). The observation that two wellcharacterized PI3K inhibitors (wortmannin and LY294002) stimulated MT assembly and
promoted the interaction of G with MTs (Figure 24A) supports the notion that inhibition
of PI3K activity in cells stimulates MT assembly by promoting the interaction of G with
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MTs. This is further supported by the fact that gallein (which binds to G and inhibits
G-dependent activation of PI3K) also stimulated MT assembly and increased the
interaction of G with MTs. Thus, it appears that G and PI3K work in concert to
regulate MT assembly in PC12 cells. Although gallein and PI3K inhibitors did not affect
the levels of MT assembly in NGF-differentiated PC12 cells, average neurite lengths
were significantly increased in the presence of all three inhibitors, and it is reasonable to
suggest that Gand PI3K worked together to regulate neurite outgrowth in PC12 cells.

We also tested whether gallein or PI3K inhibitors alter cell morphology and
localization/co-localization of G and MTs using immunofluorescence microscopy
(Figure 25A). As indicated in the figure, PC12 cell morphology was not altered in the
presence of gallein, wortmannin, or LY294002. However, an increase in the size of the
cells in the presence of all three inhibitors became apparent, and we used the 2009 Zen
software to assess these differences by measuring cell area in several microscopic
fields. The analysis showed that treatment of PC12 cells with PI3K inhibitors
significantly affected cell size, as demonstrated by an increase in cell area (Figure 25B).
The changes in cell size could be attributed to the increase in MT assembly as
observed in the presence of these inhibitors. We found that inhibitors did not alter the
patterns of localization/co-localization of G and MTs. In sum, our biochemical and
microscopic results suggest that G may coordinate with PI3K to modulate MT
assembly, which in turn may alter cell size.
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Figure 24. Inhibition of PI3K activity stimulates MT assembly and promotes the G-MT
interaction in undifferentiated PC12 cells. PC12 cells were treated with or without gallein (10
µM for 30 min.), wortmannin (0.2 µM for 1 h), and LY294002 (100 µM for 1 h). CSK and SOL
fractions were then prepared and subjected to the following: (A) Western blot using anti-tubulin
antibody as indicated in the method. MT assembly was determined by assessing tubulin
immunoreactivity in both fractions, and it is expressed as percent tubulin in CSK fraction; (B)
CSK fractions were subjected to co-immunoprecipitation with G antibody, followed by western
blotting using anti-tubulin (tubulin immunoreactivity in both immunoprecipitated (IP) and
supernatant (SUP) fractions are shown; and (C) the interaction of G with tubulin is expressed
in the graphic as percent tubulin co-immunoprecipitated with G. *p values < 0.05. **p values <
0.005.
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Figure 25. PI3K inhibitors cause changes in cell size of undifferentiated PC12 cells. PC12
cells were treated with or without gallein (10 µM for 30 min.), wortmannin (100 µM for 1 h), and
LY294002 (0.2 µM for 1 h). A) Cells were fixed and processed for confocal microscopy. G
was detected with FITC (green), and tubulin/MTs was detected with TMR (red). Scale bars are
100 μm. B) PC12 cells were images using confocal microscopy, and individual cells were
delineated using the Zen software to obtain area values (m2). *p value < 0.001.
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3.3.4. Inhibition of PI3K promotes the interaction of G with MTs and affects MT
assembly in neuronal primary cultures

Since gallein, wortmannin, and LY294002 affected MT assembly and G-MT
interactions in PC12 cells, and increased neurite outgrowth was observed in NGFdifferentiated PC12 cells, we tested the effect of these molecules in neuronal primary
cultures derived from rat brain cerebellum and hippocampus. Given the limited
availability of brain tissue, only two inhibitors (gallein and wortmannin) were tested
during biochemical experiments, but all three inhibitors were tested in confocal
microscopy experiments.

As indicated in Figure 26A and B, gallein and wortmannin promoted the G-MTs
interaction from 17.9 ± 0.9% (control cells) to 25.1 ± 2.3% and 29.8 ± 0.8%,
respectively. No interaction between G and tubulin was observed in the SOL fraction,
in either the presence or absence of inhibitors (figure not shown). Furthermore, the
effect of the PI3K inhibitors was also tested on MT assembly. However, the results
seem to differ from the findings obtained in undifferentiated PC12 cells, since gallein
and wortmannin were found to decrease MT assembly modestly in primary cultures
(Figure 26C). At this point, we are not able to explain this finding. It should be noted,
however, that PC12 cells (undifferentiated) and primary neurons are different in nature,
and future experiments will be needed to address this issue.
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Figure 26. Inhibition of PI3K signaling alters MT assembly and promotes the interaction
between G and MTs in cerebellar neurons. (A) Cerebellum primary cultures were treated
with PI3K inhibitors as previously described, and CSK/SOL fractions were extracted. CSK
fractions were subjected to co-immunoprecipitation using anti-G followed by immunoblotting
using an anti-tubulin antibody. (B) The G-tubulin interaction is expressed in the graphic as
percent tubulin co-immunoprecipitated with G in CSK fraction (bottom panel). (C) CSK and
soluble fractions were immunoblotted using an anti-tubulin antibody. Percent tubulin in CSK
fraction (MT assembly) and percent G in CSK fraction are expressed in the histograms. *p
values < 0.05. **p values < 0.005.
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The effect of gallein, and PI3K inhibitors on neuronal primary cultures was also
assessed using immunofluorescence labeling and confocal microscopy. Primary
cultures were established on glass coverslips, and were allowed to differentiate fully.
Cultures were then treated with or without inhibitors, followed by fixing and processing
for confocal microscopy. Cells were labeled for G (green) and tubulin (red) and were
examined by confocal microscopy.

In cerebellum primary cultures, control neurons displayed typical morphology,
with cells forming two long neurites that extended from both sides of the cell body, a
characteristic of cerebellar neurons in culture (Powell et al., 1997). G-MT colocalization along these processes can also be observed (Figure 27, a-c). After
treatment with 10 μM gallein for 30 min, cells still showed neuronal processes (Figure
27, d-f), although some areas in the observed slides were found to have clusters of
neurons. The PI3K inhibitors wortmannin and LY294002 did not alter neuronal
morphology (Figure 27, g-l). However, the neuronal processes appeared to be much
longer than those observed in the control cells.

Hippocampal primary cultures were also employed to study the effect of gallein
and PI3K inhibitors on G-MT co-localization and neuronal morphology. Normal
morphology was observed in control hippocampal neurons (Figure. 28, a-c), with cells
displaying a very long process (usually the axon), and several shorter neurites (which
have the characteristics of dendrites). This morphology is typical of hippocampal
neurons in culture (Dotti et al., 1988). Treatment with gallein does not appear to affect
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neuronal morphology, as cells still display the features described above (Figure 28, d-f).
However, treatment with the PI3K inhibitors wortmannin and LY294002 seems to alter
hippocampal neuron morphology dramatically (Figure 28, g-l). Cells treated with these
compounds seemed to have longer neurites, and the presence of a neuronal process
longer than the others (a typical feature of these neurons in culture) was not detected.
In addition, tubulin labeling in the neurites appeared to be decreased (Figure 28, h, k),
suggesting that cytoskeletal reorganization occurs in response to the inhibition of PI3K
signaling.
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Figure 27. PI3K inhibitors alter neurite development in cerebellar cultures. Cerebellum
primary cultures were established on pre-coated glass coverslips. The cultures were then
treated with or without gallein (10 µM for 30 min.), wortmannin (0.2 µM for 1 h), and LY294002
(100 µM for 1 h), and cultures were fixed and processed for confocal microscopy. G is shown
in green (FITC labeling), and tubulin is shown in red (TMR labeling). Colocalization patterns are
shown in the merged images. Scale bars are 100 μm.
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Figure 28. PI3K inhibitors affect neurite outgrowth in hippocampal primary neurons from
rat brains. Hippocampal primary cultures were established on pre-coated glass coverslips. The
cultures were then treated with or without gallein (10 µM for 30 min.), wortmannin (0.2 µM for 1
h), and LY294002 (100 µM for 1 h), and cultures were fixed and processed for confocal
microscopy. G is shown in green (FITC labeling), and tubulin is shown in red (TMR labeling).
Colocalization patterns are shown in the merged images. Scale bars are 20 μm.
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3.3.5. PI3K inhibitor wortmannin inhibits the association of pAkt with the CSK
fraction in primary neurons from rat brain cerebellum

Phosphorylation of Akt is known to occur due to upstream PI3K activity. PI3K/Akt
signaling pathway plays a critical role in the regulation of MT stability in directed cell
migration in NIH3T3 fibroblast cells, as well as during neurite outgrowth of PC12 cells
(Cantley, 2002; Zhou et al., 2004). Therefore, we investigated whether inhibition of PI3K
signaling affects the association of Akt/pAkt with MTs in cerebellar primary neurons.
CSK and SOL fractions from cerebellar cultures treated with wortmannin, and gallein
and subjected to immunoblotting using anti-Akt and anti-pAkt antibodies.

The results show that the association of total Akt with the CSK fraction appears
to increase, albeit not significantly in the presence of gallein or wortmannin (Figure
29A). Gallein, which is known to specifically inhibit G-mediated activation of PI3K-,
did not affect the association of pAkt in the CSK fraction. However, treatment of
cerebellar neurons with wortmannin, a general PI3K inhibitor, completely abolished the
association of phosphorylated Akt with MTs (Figure 29B). The result suggests that while
overall inhibition of the PI3K/Akt/pAkt signaling pathway appears to favor the G-MT
mediated pathway, as demonstrated by stimulation of MT-G interactions, MT
assembly, and neurite outgrowth (Figures 22-28), gallein (which binds to G) does not
interfere with downstream signaling of PI3K (Akt/pAkt).
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Figure 29. Inhibition of PI3K with wortmannin abolishes the association of pAkt with the
CSK fraction in PC12 cells. Cerebellum primary cultures were treated with PI3K inhibitors as
described previously, and CSK/SOL fractions were extracted. CSK fractions were subjected to
immunoblotting using anti-Akt (A, top panel), and anti-pAkt (B, top panel) antibodies. The
histograms (A, B, bottom panels) show percent Akt (A) or pAkt (B) in the CSK fraction.
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CHAPTER 4: DISCUSSION

Neuronal outgrowth and plasticity is a complex phenomenon that requires the
coordination of different cellular mechanisms. While many signals are known to drive
the process, it is the assembly and disassembly of cytoskeletal structures that take the
form of neurite extension and synapse formation that is essential to establish
appropriate synaptic connections and for the brain’s ability to store and process signals.
Dynamic rearrangement of MTs and AFs is critical for growth cone motility and neurite
outgrowth. Although several signaling pathways involving a large number of proteins
and lipids in regulating neurite outgrowth have been identified, the linkage between
these pathways and how they ultimately converge to regulate assembly and
disassembly of MTs and AFs is not well understood (Tahirovic and Bradke, 2009; Wang
and Wong, 2009). The results presented here demonstrate that the regulated interaction
of G with MTs may be critical for neurite outgrowth and differentiation, and that NGF
could facilitate the process by promoting this interaction. Thus, G may play a key role
during neuronal differentiation by linking extracellular signals to the cytoskeletal
filaments, exerting the changes that are required for neurite outgrowth.

Although G has been shown to bind to tubulin and to promote MT assembly in
vitro and in cultured PC12 and NIH3T3 cells (Roychowdhury and Rasenick, 1997;
Roychowdhury et al., 2006; Montoya et al., 2007; Roychowdhury and Rasenick, 2008),
the functional implication of this interaction has not been demonstrated. Reports from
several laboratories have indicated the involvement of G in neuronal development
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and differentiation (Sanada and Tsai, 2005; Sachdev et al., 2007). G1-deficient mice
have been shown to have neural tube defects (Okae and Iwakura, 2010), and G5knockout mice have been shown to display abnormal behavior and develop multiple
brain abnormalities (Zhang et al., 2011). Earlier, it was shown that impaired G
signaling promoted neurogenesis in the developing neocortex and increased neuronal
differentiation of progenitor cells (Sanada and Tsai, 2005). Although the mechanism by
which G controls this process is not yet understood, the possibility that G may act
on MTs has been suggested. Sachdev et al. (2007) have also suggested that GTctex-1 complex plays a key role in regulating neurite outgrowth in primary hippocampal
neurons, most likely by modulating MTs and actin filaments. These studies suggested a
connection between G signaling and the modulation of MTs during neurite outgrowth
and development. The data presented here clearly suggest that the interaction of G
with MTs, and G’s ability to stimulate MT assembly, may provide a mechanism by
which Gregulates neuronal differentiation.

Overexpression of G in PC12 cells leads to neurite outgrowth in the absence of
NGF, further supporting a key role for G during neuronal differentiation. Based on our
high-resolution image analysis of the neuronal processes induced by overexpression of
G (Fig. 12), it appears that MT filaments and G interact throughout the neuronal
processes, as evidenced by clear yellow labeling. G labeling (green) was also
observed side by side with yellow labeling throughout the neuronal process from all
directions. This labeling pattern appears to support our in vitro results, which indicates
that G binds laterally on the MT walls (Roychowdhury and Rasenick, 1997). The
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decoration of MTs by G appears to be strikingly similar to that observed by MAPs
(Murphy and Borisy, 1975). In this context,  subunits might represent a new class of
microtubule-regulatory molecules similar to MAPs. Like MAPs, G preferentially
associated with microtubules in PC12 cells (Figure 7; Montoya et al., 2007) and MTs
assembled in vitro in the presence of G (Roychowdhury and Rasenick, 1997). MAP2,
a well-studied MAP, is involved in the initiation of neurite outgrowth and dendrite
development. At later developmental stages, MAP2 disappears from axons but is
retained in dendrites (Bernhardt and Matus, 1984; Cáceres et al., 1986). Tau regulates
MT assembly and neurite outgrowth, and is found only in axons (Binder et al., 1985). It
is possible that G, which is central to G protein-coupled signaling pathways, could
mediate the interactions of MAP2/Tau with MTs/actin filaments during neurite
outgrowth.

The interdependence between MTs and actin filaments in regulating neurite
outgrowth has been previously demonstrated by using pharmacological inhibitors of
actin polymerization and MT assembly. The inhibition of actin polymerization resulted in
rapid MT advance and axon growth. Conversely, MT dynamics are required for directed
growth-cone motility. MT-actin interactions also occur in the central domain of the
growth cone, where actin filaments facilitate MT bundling, which is a requirement for
axon formation (Bentley and Torojan-Raymond, 1986; Witte and Bradke, 2008; Geraldo
and Gordon-Weeks, 2009). The distinctive co-localization pattern of G with actin
filaments at the tip of the neurites and with MTs at the growth cones of PC12 cells
(Figure 14) supports the idea that G functions to mediate the interactions between
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MTs and actin filaments. Moreover, axon branching, which requires interactions
between MTs and actin filaments (Griffith and Pollard, 1982), was observed in Goverexpressing PC12 cells (Figure 9), further suggesting the involvement of G in MTactin filaments coupling. More recently using CHO cell lines, it has been shown that
MTs play an important role in restraining cell movement and establishing directionality
(Ganguly et al., 2012). G which is found in the leading edge of PC12 cells could be
involved in regulating this process by interacting with MTs.

Previously, by using a prenylation-deficient mutant of 12, 12 (C68S), we have
shown that prenylation and further carboxy-terminal processing (methylation) of the 
subunit of G are important for interaction with MTs and stimulation of MT assembly in
vitro (Roychowdhury et al., 1997). We decided to target the post-prenylation processing
enzyme PMPMEase in this study for two reasons. First, although prenylation has been
studied extensively because of the prevalence of prenylated proteins in cancer biology,
and the prenyl transferase enzyme has been targeted for clinical trials, the results so far
have not been promising; therefore, attention has recently been diverted to postprenylation pathways. The enzyme involved in methylation of the prenylated protein,
isoprenylcysteine carboxyl methyltransferase (ICMT), is now being studied for cancer
metastasis, and results appear to be promising (Lamango, 2005; Winter-Vann and
Casey, 2005; Gelb et al., 2006; Cushman and Casey, 2011). Recent studies have
indicated that targeting ICMT might be useful in treating the rare genetic disease
progeria (Ibrahim et al., 2013). Second, inhibitors for PMPMEase have recently been
synthesized, and they have been shown to induce degeneration of human
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neuroblastoma SHSY5Y cells (Aguilar et al., 2011). Although the  subunit of G may
not be the only target of PMPMEase (the Rho and Ras families of GTPases also
undergo prenylation and subsequent methylation/demethylation), based on previous
findings that the major protein that undergoes in vivo methylation in rat brains in
response to injection of endogenous methyl donor S-adenosyl methionine is a molecule
with a molecular weight comparable to that of the  subunit of G proteins (Lamango and
Charlton, 2000; Lamango et al., 2003). Therefore, it is likely that the  subunit of the G
protein was a major target of PMPMEase inhibition in our experiment. In addition, the
tested PMPMEase inhibitors were proved to cause neuronal damage, alterations in the
MT cytoskeleton, and changes in G organization in three different neuronal cell model
systems: NGF-differentiated PC12 cells, SH-SY5Y neuroblastoma cells, and primary
neurons from rat cerebellum. These findings support the notion that PMPMEase could
be a key regulator of the G-MT interaction, and makes it an attractive candidate for
future therapeutic targeting in neurodegenerative diseases.

Accumulating evidence suggests that PI3K-mediated signaling plays a critical
role in the regulation of neuronal outgrowth and differentiation. PI3K is an enzyme that
belongs to a family of lipid kinases that phosphorylate phosphoinositides. One of these
products, phosphotidylinositol 3,4,5-triphosphate (PIP3), serves as a second messenger
to trigger a variety of cellular responses, including proliferation, differentiation, survival,
and metabolism (Whitman et al., 1988; Shepherd et al., 1998; Kong and Yamori, 2008;
Knight, 2010). Two downstream effectors of PI3K that have been shown to participate in
the regulation of neurite outgrowth and are particularly associated with cytoskeletal
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remodeling, are Akt and the glycogen synthase kinase 3 (GSK3). The PI3K/Akt
pathway has been shown to be responsible for mediating neurotrophin responses,
which are critical for neuronal outgrowth (Wu and Wong, 2005a and 2005b; Wu and
Wong, 2006). In addition, it has been demonstrated that Akt signaling is involved in
axonal regeneration (Verma et al., 2005). In the case of GSK3, this kinase is known to
work in concert with PI3K in order to regulate the differentiation of hippocampal neurons
(Jiang et al., 2005; Yoshimura et al., 2005). Our results clearly suggest that PI3K
signaling and G coordinate to regulate MT assembly and neurite outgrowth as
demonstrated in the proposed model (Figure 30). In this model, NGF-induced activation
of TrkA and subsequent activation of PI3K/Akt/pAkt is shown in left panel. Promotion of
MT-G interaction and subsequent alteration of MT assembly and neurite outgrowth
(as demonstrated in the current research) is shown in the central panel. Inhibitors of
PI3K (wortmannin and LY294002) block the PI3K/Akt/pAkt pathway (left panel, Figure
30) as shown by inhibition of the association of pAkt with cytoskeletal fraction (Figure
29). As indicated in the model (Figure 30), blocking this pathway upregulates G-MT
mediated pathway (central panel) and neurite outgrowth. A similar effect on G-MT
mediated pathway was observed in the presence of gallein, which is known to bind to
G and activate PI3KHowever, gallein did not affect Akt/pAkt pathway (Figure 29)
suggesting that unlike PI3K inhibitors, which affected G-MT dependent neurite
outgrowth, gallein may not alter PI3K/Akt/pAkt pathway. Our results clearly indicate that
PI3K and its downstream effectors are important regulators of G-MT mediated
pathway, and cross-talk between these two pathways is important for neurite outgrowth.
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Figure 30. G-MT mediated pathway and PI3K signaling coordinate to regulate MT
assembly and neurite outgrowth. The proposed model shows that NGF acts through TrkA
receptors to activate PI3K and its downstream effectors (left panel). The results presented here
demonstrate that NGF utilizes G, a key component of the GPCR pathway (right panel), to
alter MT assembly by means of its interaction with MTs, ultimately leading to neurite outgrowth
and differentiation (central panel). Inhibition of PI3K blocks downstream effector Akt/pAkt, which
seems to positively influence the G-MT mediated mechanism of neurite outgrowth. Blocking of
G-mediated activation of PI3K by gallein does not affect the PI3K pathway, but it does favor
the G-MT mediated pathway.
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It has been shown earlier that in contrast to G, which promotes MT assembly,
G inhibits MT assembly and stimulates MT dynamics by activating the intrinsic
GTPase activity of tubulin (Roychowdhury et al., 1999). In addition, evidence from
several laboratories indicates that G-dependent signaling pathways are involved in
regulating neurite outgrowth (Strittmatter et al., 1994; Chen et al., 1999; He et al., 2005;
Jordan et al., 2005; Bromberg et al., 2011). More recently, it has been shown that
overexpression of activated, GTP-bound Gs (Q204L Gs), but not wild-type Gs in
PC12 cells increases MT dynamics and induces neurite formation (Yu et al., 2009). It
was suggested that activated Gs promotes neurite outgrowth by increasing MT
dynamics. However, neurite outgrowth involves a dramatic reorganization of MTs, and
therefore requires precise control of disassembly and assembly of MTs. It is known that
rapid polymerization of MTs is essential for neurite (axon and dendrite) formation, and
G could play an important role in this process. We have shown earlier that G protein
activation and subsequent dissociation of  (GTP-bound active form) and  subunits
are necessary for modulation of MT assembly by G proteins (Roychowdhury et al.,
2006). Since activated Gs (GTP-bound) does not bind to G, it is possible that while
activated Gs can increase MT dynamics, it is the free G (not bound to Gs) that
stimulated MT assembly and participated in inducing neurite outgrowth, as observed by
Yu et.al (2009). This is further supported by our observation that the overexpression of
G induces neurite outgrowth in the absence of NGF. Clearly, further investigation will
be required to understand the in-depth mechanisms by which G induces neurite
outgrowth and the molecules that are involved in this process.
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One of the unique features of G is its ability to interact with a large number of
structurally and functionally diverse binding partners (Ford et al., 1998; Smrcka, 2008).
Crystal structure and biochemical studies identified a region in G as a “hot spot,”
where multiple effectors interact in such a way that they partially overlap one another
(Scott et al., 2001; Davis et al., 2005; Lehmann et al., 2008; Mathews et al., 2008), and
NMR analysis reveals that G adopts a range of conformations that can be exploited
during molecular recognition by diverse binding partners (Bonacci et al., 2006).
Although direct interaction between G with tubulin has been demonstrated
(Roychowdhury et al., 2006), G-tubulin interacting domain(s) have not been explored
yet. Based on the literature, it is likely that tubulin binds to the “hot spot” region of G,
since the majority of G effectors bind to this region. Moreover, the results presented
here identify the MT cytoskeleton as a new class of effector of Gsignaling during
neurite outgrowth.

The dramatic rearrangement of MTs during neuronal differentiation is critical for
vesicular transport, neurotransmitter release, and communication at the synapse.
Recent results suggest that G regulates the formation of SNARE complex, an
essential step for neurotransmitter release of a synapse (Blackmer et al., 2005; Yoon et
al., 2007). More recently, G has been shown to inhibit dopamine transporter activity
(Garcia-Olivares et al., 2013). Although it is not clear whether these events are
interlinked, it is tempting to speculate that signals originating from cell-surface receptors
utilize G to induce specific changes in MT assembly and organization in axons, which
may in turn contribute to the G-dependent transport and neurotransmitter release of a
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synapse. G is known to activate a diverse array of effector molecules, including
adenylate cyclases, phospholipases, PI3K, and ion channels. Future investigation will
be important to understand how these effector systems influence G-dependent
regulation of MTs and neuronal differentiation.

Recent results have indicated that MT assembly is severely compromised in the
early stages of Alzheimer’s and Parkinson’s diseases (Cash et al., 2003; Buxton et al.,
2010; Cartelli et al., 2010; Cartelli et al., 2013). Defects in MT-based transport are
thought to be associated with many neurological disorders, including Alzheimer’s
disease, Huntington’s disease, and ALS (De Vos et al., 2008; Millecamps and Julien,
2013; Franker and Hoogenraad, 2013), and disruption of the underlying microtubule
network could be one way the transport is impaired (Franker and Hoogenraad, 2013).
The data presented here support the notion that the altered interaction of G with MTs
may cause disruption of MTs and may trigger an early stage of neurodegeneration.
Therefore, our results identify G as a potential key molecule for future therapeutic
development for the treatment of neurodegenerative diseases.
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